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ABSTRACT OF DISSERTATION 
 
 
 
EXAMINATION OF THE SNSAG SURFACE ANTIGEN GENE FAMILY IN 
SARCOCYSTIS NEURONA 
 
Sarcocystis neurona is a protozoan parasite that causes the serious neurologic 
disease equine protozoal myeloencephalitis (EPM). The life cycle of S. neurona 
progresses through multiple developmental stages that differ morphologically and 
molecularly. The S. neurona merozoite surface is covered by multiple related proteins, 
which are orthologous to the surface antigen (SAG) gene family of Toxoplasma gondii. 
The SAG surface antigens in T. gondii and another related parasite Neospora caninum are 
life cycle stage-specific and seem necessary for parasite transmission and persistence of 
infection. The present research was conducted to explore the gene family of SnSAGs in S. 
neurona. Specifically, the project identified new SnSAGs in the draft genome sequence 
of S. neurona and examined the stage-specific expression and potential function of these 
surface antigens. For the first part of the study, expression of the S. neurona merozoite 
surface antigens was evaluated in the sporozoite and bradyzoite stages. The studies 
revealed that SnSAG2, SnSAG3 and SnSAG4 are expressed by sporozoites, while 
SnSAG5 appeared to be downregulated in this life cycle stage. In S. neurona bradyzoites, 
SnSAG2, SnSAG3, SnSAG4 and SnSAG5 were either absent or expression was greatly 
reduced. For the second part of the study, the draft sequence of the S. neurona genome 
was searched for potential new SnSAGs. Multiple searches revealed sixteen potential 
new SnSAG genes, and bioinformatic analyses of the sequences revealed characteristics 
consistent with the SAG gene family. Two of the new SnSAGs, designated SnSAG7 and 
SnSAG8, have been characterized in detail. The studies showed that SnSAG7 is 
expressed by the merozoite stage, while SnSAG8 is expressed by the bradyzoite stage. 
The third part of the study assessed the role of SnSAGs in host cell attachment and/or 
invasion by S. neurona. Serum neutralization assays using polyclonal serum raised 
against SnSAG1, SnSAG2, SnSAG3, and SnSAG4 suggested that SnSAG1 and SnSAG4 
play a role in host cell attachment and/or invasion; treatment with antibodies against 
SnSAG2 and SnSAG3 were inconclusive. The information acquired about the stage-
specific expression of the SnSAGs, identification of new SnSAG paralogues, and their 
functional characterization will help to understand the importance of the SnSAG proteins 
for parasite survival and could lead to improved methods for EPM prevention and/or 
treatment. 
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Chapter 1 
Introduction and Hypothesis 
1.1 Introduction 
Sarcocystis neurona is an apicomplexan parasite that is the primary cause of 
Equine Protozoal Myeloencephalitis (EPM) [1, 2].  EPM is the most commonly 
diagnosed neurological disease of horses causing significant economic losses in the 
United States [2]. Horses severely affected with EPM can have difficulty in standing, 
walking or swallowing [2]. EPM is responsible for economic loss by causing decreased 
performance time, loss of stake payments, transport costs, and sometimes death. Annual 
losses due to EPM have been estimated at more than 100 million dollars in the United 
States [2]. The disease poses challenges in terms of diagnosis and treatment. Differential 
diagnosis of EPM is difficult and is often misdiagnosed with other neurological disorders. 
Of particular importance, not all horses that are infected with S. neurona exhibit clinical 
disease; however, it is not clear what factors make the horses susceptible to develop 
EPM. Also, the chemotherapeutic agents available for EPM are expensive and prognosis 
is sometimes poor since the treatment is often started after the central nervous system 
(CNS) has been irreversibly damaged. In addition to causing disease in horses, incidences 
of neurologic disease in sea mammals have been attributed to S. neurona [3-8].   
The natural life cycle of this parasite alternates between the definitive host, the 
opossum [9], and intermediate hosts such as skunks [10], raccoons [11], armadillos [12], 
and cats [13].  The life cycle includes both sexual and asexual modes of reproduction.  
Sporulated oocysts containing infectious sporozoites are a product of sexual 
reproduction, which takes place in the intestine of the opossum, the definitive host.  This 
environmentally-resistant cyst stage is shed in the opossum feces and serves as the source 
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of infection for intermediate hosts.  Asexual reproduction of S. neurona in the 
intermediate hosts produces two developmental stages called merozoites and bradyzoites. 
Merozoites propagate rapidly in a variety of cell types through a process called 
endopolygeny, while bradyzoites are a much slower-growing stage that form sarcocysts, 
most commonly in muscle tissue [14, 15] 
The cell surface of S. neurona merozoites is covered with an array of paralogous 
glycosylphosphatidylinositol (GPI)-anchored surface antigens called SnSAGs [16, 17]. 
These surface proteins were identified based on their homology to the gene family of 
TgSAGs and SAG1-related sequences (SRSs) of the related apicomplexan parasite 
Toxoplasma gondii [18]. A total of six SnSAGs have been described in S. neurona, with 
only a subset of these SnSAGs expressed by individual parasite strains [16, 17, 19].  
An extensive search of T. gondii genome using bioinformatic tools has revealed a 
superfamily of 182 SRS proteins [20, 21]. The members of this family belong to either of 
the prototypes, SAG1 or SAG2A [20]. Most characterized members of this family are 
expressed in a stage specific manner. The functional role of these surface antigens has not 
been clearly defined.  However, there is evidence to suggest that the SAG proteins are 
involved in host cell invasion, immune modulation and/or virulence attenuation [22-25].  
It has been proposed that the tachyzoite-specific SAGs are involved in regulation of 
virulence and elicitation of immune response to give rise to an acute infection, while the 
bradyzoite-specific SAG molecules may be important for immune evasion and 
persistence of a chronic infection [24, 25]. 
My dissertation research examines the SnSAG surface antigens to better 
comprehend host-parasite interactions, complexities in parasite stage conversion during 
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the life cycle, and the proteins involved in these processes. The information acquired may 
be useful for developing better diagnostics, therapeutics, and preventive measures. 
1.2 Hypotheses 
Hypothesis 1: The SnSAG surface antigens of S. neurona exhibit stage-specific 
expression 
Objectives: 
 Determine expression of SnSAGs in merozoites vs. sporozoites 
 Determine expression of SnSAGs in merozoites vs. bradyzoites 
Rationale: The S. neurona must infect a variety of different tissues and host animals 
during its complete life cycle. Thus, different surface molecules might be expressed by 
the sporozoite stage versus the merozoite stage versus the bradyzoite stage of the parasite. 
In support of this idea, studies on the related parasite T. gondii have revealed stage 
specific TgSAG expression; TgSAG1 and TgSAG2 are specific to the tachyzoite stage, 
while SRS proteins P36, P21, and SAG4 are bradyzoite specific.  
 
Hypothesis 2: The S. neurona genome contains an extensive gene family of SnSAGs. 
Objectives: 
 Search the S. neurona genome sequence for potential SnSAGs genes 
 Examine each putative SnSAG locus in detail 
 Raise antisera against new SnSAGs to characterize the proteins 
 Determine strain and stage-specific expression of new SnSAGs 
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Rationale: There are 182 SAG-related sequences identified in the T. gondii genome. 
However, only 6 SAGs/SRSs have been identified in S. neurona to date. It is expected 
that more members of the SAG/SRS gene family exist in S. neurona. 
 
Hypothesis 3: Surface antigens play an important role in host cell attachment and/or 
invasion. 
Objectives:  
 Determine whether antibodies against SnSAGs alter host cell attachment 
and invasion by the parasite 
Rationale: Studies on T. gondii have demonstrated that various TgSAGs are associated 
with host cell attachment, invasion, virulence, and immune modulation. Like T. gondii, S. 
neurona is an obligate intracellular parasite in which host cell attachment and invasion 
are critical components of its life cycle. SnSAGs present on the parasite surface might 
have an important role in the parasite’s ability to attach to and then invade host cells. 
 
 
 
 
 
 
 
 
Copyright © Ablesh Gautam 2014 
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Chapter 2 
 Literature Review 
2.1. Sarcocystis neurona 
Sarcocystis neurona is an obligatory intracellular parasite, belonging to the 
phylum Apicomplexa. The phylum includes protozoan parasites of both medical and 
veterinary importance for example Plasmodium spp., the lethal cause of malaria; Babesia 
and Theileria spp., cattle parasites; Cryptosporidium parvum, an opportunistic animal and 
human pathogen; Eimeria spp., a poultry and cattle pathogen; Toxoplasma gondii, human 
or any other warm-blooded animal pathogen; and Neospora spp, an animal pathogen 
(Figure 2.1). However, S. neurona is more closely related to the gut/ tissue dwelling 
parasites T. gondii and Neospora spp. The S. neurona was first reported in the lesions of 
segmental myelitis from horses by three separate research groups in 1974, but it was 
misidentified as T. gondii [26-28]. It was later in 1991 that, Dubey et al. isolated this 
protozoan from an infected horse, and based on the parasite’s structural features, 
proposed the name Sarcocystis neurona [1]. 
2.2. Equine protozoal myeloencephalitis 
Sarcocystis neurona is the primary cause of the most common neurological 
disorder in horses called Equine Protozoal Myeloencephalitis (EPM).  In addition to 
horses, S. neurona has also been reported to cause the neurological disease in sea 
mammals [3-8].  EPM is a serious neurological disorder of horses in North, Central, and 
South America, most often caused by S. neurona, and less commonly by Neospora 
hughesi [2, 29-31]. Seroprevalence rate of EPM remains higher (30-50%) than the 
disease incidence rate, which is less than 1% [2, 32]. This indicates that not all exposed 
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horses are severely affected. However, it’s not clear that what factors lead to the 
progression of a simple infection to a severe neurologic disease.  
In horses, S. neurona infection seems to be restricted to the central nervous 
system (CNS) [33-35]. Clinical symptoms are dependent upon the region of CNS 
affected. Parasitizing of cerebrum may lead to depression, behavioral changes or seizures. 
Involvement of brainstem and spinal cord may cause gait abnormality and incoordination 
and various signs attributable to damage of cranial nerve nuclei [33, 36]. These signs are 
characterized by facial nerve paralysis, head tilt, ataxia of one or more limbs, and a 
tendency to lean to one side, paralysis of the tongue, urinary incontinence, dysphagia, and 
atrophy of masseter-temporal muscles [2]. Involvement of spinal cord only leads to one 
of the more common neurological disease called cervical vertebral myelopathy [2, 37, 
38], which is caused by stenosis of the vertebral canal and often may be accompanied by 
instability between the vertebrae. Grey matter if damaged severely may cause weakness 
and atrophy of innervated muscles of the limbs. Some affected horses may also 
experience abnormal functioning of upper respiratory tract [2]. Horses severely affected 
with EPM may find difficulty while standing, walking or swallowing. The disease may 
progress quite rapidly, while in some cases the disease might stabilize for a certain period 
of time [2].  
2.3. Life cycle 
The natural life cycle of S. neurona exchanges between the definitive host, the 
opossum (Didelphis virginiana) [9], and small mammal intermediate hosts such as skunk 
[10], raccoon [11], armadillo [39], cat [13], and sea otter [3] (Figure 2.2).  Sarcocystis 
neurona reproduces both sexually and asexually. Sexual reproduction takes place in the 
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intestine of the opossum, the definitive host and produces sporulated oocysts that contain 
infectious sporozoites. Intermediate hosts get infected by ingesting these 
environmentally-resistant cysts shed in the opossum feces. Asexual reproduction of S. 
neurona in the intermediate hosts produces primarily two developmental stages called 
merozoites and bradyzoites. Merozoites propagate rapidly through a process called 
endopolygeny, while bradyzoites, a much slower-growing stage form sarcocysts, most 
commonly in muscle tissue [14, 15]. The definitive hosts get infected when they 
scavenge upon muscles of the intermediate hosts containing sarcocysts. Upon ingestion, 
bradyzoites are released from the sarcocysts inside the intestine of definitive hosts where 
they undergo sexual propagation and form oocysts. Horses get infected upon ingestion of 
food and/or water contaminated with opossum feces containing the infective sporocysts. 
Horses are aberrant hosts in this life cycle since tissue cyst formation has not been 
commonly demonstrated. However, there has been one study that reported formation of 
tissue cyst in a foal with EPM [40]. 
2.4. Cell division  
The process of endopolygeny includes a total of six replication cycles that finally 
leads to the production of 64 merozoites. For the first five cycles there is only 
chromosomal duplication and segregation taking place that results into 32N cell. 
Following that, nuclear division and cytokinesis takes place during the sixth cycle, thus 
resulting into formation of 64 merozoites [41]. The newly-formed merozoites can either 
reside in the same host cell or they can lead to the lysis of the host cell and thus escape to 
infect nearby host cells. 
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2.5. Ultrastructure  
Toxoplasma gondii is one of the well-studied members of the Apicomplexans. 
The parasites are often crescent shaped consisting of various organelles. There is an outer 
covering called pellicle consisting of three membranes, a plasmalemma and two flat 
membranous vesicles forming the inner membrane complex (IMC) [42]. It is believed 
that this micropore participates in nutrient uptake by endocytosis [43]. 
Toxoplasma gondii has a characteristic specialized anterior end called apical 
complex, which is comprised of the rhoptries, the micronemes, the apical polar ring, and 
the conoid (Figure 2.3). Rhoptries are club-shaped while micronemes are cigar-shaped 
secretory organelles [44, 45]. Rhoptries and microneme proteins play an important role in 
the process of parasite motility, attachment and invasion of the host cells, and 
establishment of the parasitophorous vacuole (PV) [44, 46]. The conoid is a cone-shaped 
special structure surrounded by two preconoidal rings on the top. The apical polar ring is 
the hallmark organelle of the Apicomplexan parasites [45]. The apicomplexans also have 
a specialized chloroplast-like organelle called the apicoplast [47, 48] (Figure 2.3). Most 
apicomplexan parasites have common cytoskeletal elements such as microtubules, actin, 
myosin, and intermediate filament-like proteins [44]. Apart from these organelles, 
apicomplexan parasites also have a Golgi complex, mitochondria, dense granules, lipid 
bodies, amylopectin, rough endoplasmic reticulum, and a nucleus and nucleolus [46]. 
Dense granules are present throughout the parasite uniformly, and the proteins of this 
organelle, called GRA proteins, are secreted after the completion of the invasion process 
(Figure 2.3). GRA proteins are believed to help in modifying the parasitophorous vacuole 
and acquire nutrients from the host cell [49]. In T. gondii, the surface of the parasite is 
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covered by an array of glycosylphosphatidylinositol (GPI)-anchored proteins/antigens, 
known as surface antigens (SAGs) [50] (Figure 2.3).  
Sarcocystis neurona possess most of the structural features of the Apicomplexan 
parasites, however, there are some distinct features. For example, rhoptries are absent in 
merozoite stage of S. neurona, a stage comparable to tachyzoite in T. gondii. Also, unlike 
T. gondii, S. neurona doesn’t form a PV while residing inside a host cell [2, 15]. 
2.6. Surface antigens in apicomplexan parasites 
The surface of T. gondii is decorated with GPI-anchored proteins/antigens, 
referred to as SAGs [18], and collectively known as SRS (SAG1-related sequences) 
superfamily of proteins (Figure 2.3). These surface antigens are developmentally 
regulated, structurally related, yet antigenically distinct. An extensive search of T. gondii 
genome using bioinformatic tools has revealed a superfamily of 182 SRS proteins [20, 
21]. The members of this family belong to either of the prototypes, SAG1 or SAG2A 
[20]. All SRS proteins have an N-terminal signal peptide sequence, as would be predicted 
for proteins destined for transportation to the outer surface. They all have a hydrophobic 
C-terminal GPI anchor by which they are tethered to the outer surface membrane of the 
parasite. SRS proteins share 24-99% amino acid sequence identity. The prototypic SAG1 
has a homodimeric configuration of two dumbbell-shaped monomers (Figure 2.4). The 
structure of SAG1 antigen in T. gondii, has a basic groove which seems to be conserved 
among SRS proteins and potentially mediates binding to the sulfated proteoglycans on 
the host cell surfaces [51, 52]. The N-terminal domain faces outward and is connected to 
the C-terminal domain that is connected to the surface of the parasite. Each domain has 6 
conserved cysteine residues that participate in disulfide bonding, thus making a total of 
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12 cysteine residues in both the domains. SAG2A and SAG2B are the smallest members 
of the SRS superfamily and have a single domain. All other members of this superfamily 
seem to possess two SAG2A-like domains [51]. 
Neospora caninum has a vast repertoire of SRS genes expressed by all three 
stages. A recent genome study of N. caninum has revealed an expanded family of 279 
NcSRS genes, including 52 NcSRS pseudogenes [53] against 181 TgSRS genes in T. 
gondii. However, T. gondii expresses greater number of SRSs than N.caninum (55 vs. 25 
respectively) during the tachyzoite stage [53]. Some of these SRSs have been 
characterized in detail. NcSAG1 and NcSRS2 are expressed by tachyzoites and 
participate in host cell invasion [54, 55]. NcSAG4, NcBSR4 and NcSRS9 are bradyzoite-
specific antigens expressed either early or late during stage conversion [56-58].  
Neospora hughesi is an apicomplexan parasite that causes EPM in horses [2, 29, 
30]. N. hughesi is distinct from N. caninum ultrastructurally, antigenically and 
molecularly [29]. Two conserved immunodominant surface antigens belonging to 
SAG/SRS superfamily; NhSAG1 and NhSRS2, have been characterized in N. hughesi 
[59]. Both these surface antigens are expressed by tachyzoites. NhSAG1 share 94% 
whereas NhSRS2 share 91% amino acid identity to their N. caninum counterparts. 
NhSAG1 is currently used in ELISA to detect antibodies against N. hughesi in equine 
serum [60].  
The role of surface antigens in interacting with the immune response in the host 
has been well established in other Apicomplexan parasites as well. For an instance, 
antigenic variation is the key strategy for survival employed in Plasmodium falciparum 
(Su et al., 1995). Furthermore, it has been suggested that Plasmodium expresses a large 
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number of related proteins by which immune response to either of them or probably to 
the major one is decreased (Anders, 1986). This is mediated by the fact that immune 
response against any of the members of the family could be downregulated by the 
peptides that are similar but non-identical, creating an immune confusion which hinders 
in eliciting an efficient response by the host. Surface antigens have also been 
demonstrated in Eimeria spp., in sporozoite and merozoite life cycle stages [61-64]. The 
eponymic protein SAG1 has been characterized and cloned from E. tenella and is 
considered as a promising vaccine candidate [61, 64]. 
2.7. Stage-specific expression of surface antigens 
Stage-specific expression of the SAG/SRS proteins has been demonstrated in both 
T. gondii and Neospora caninum [25, 56, 57, 65-69].  It has been proposed that the 
tachyzoite-specific SAGs are involved in regulation of virulence and elicitation of 
immune response to give rise to an acute infection, while the bradyzoite-specific SAG 
molecules may be important for immune evasion and persistence of a chronic infection 
[24, 25].  Less is known of SAG/SRS gene family members expressed during the 
sporozoite stage. 
In T. gondii, the tachyzoite surface displays a mixture of SAG/SRS molecules, 
including TgSAG1, SAG2A, SAG3, SRS1, SRS2, SRS3 as well as several other less-
highly-expressed SRSs [70].  In contrast, an alternative array of SAGs/SRSs such as 
SAG2C and D, SRS9, SAG4 and BSR4 appear to decorate the T. gondii bradyzoite 
surface [66-68]. Likewise, NcSAG1 and NcSRS2 have been found to be tachyzoite 
specific in N. caninum [71, 72], while the proteins NcSAG4 and NcBSR4 are specifically 
expressed during the N. caninum bradyzoite stage [56, 57]. Sporozoites of T. gondii 
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appear to lack the tachyzoite surface proteins TgSAG1 and TgSAG2A, but instead 
express SporoSAG and a still-unidentified surface protein of approximately 67 kDa [50, 
69, 73]. 
There is significant evidence that the SAG/SRS gene families in coccidian 
parasites function in both host cell adhesion/invasion and in immune modulation and 
parasite persistence.  Multiple studies utilizing monoclonal antibodies (mAbs) or SAG-
deficient mutants of T. gondii have implicated a role for various members of this gene 
family in the process of adhering to and invading host cells, although the results of these 
studies suggested that each SAG/SRS paralogue might function differently in the process 
[22, 23, 74, 75]. In addition, it is apparent that expression of the bradyzoite-specific 
SAG/SRS proteins is important for the parasite’s ability to establish and maintain latent 
cysts in host tissues [24, 25, 76]. These studies collectively suggest that T. gondii 
persistence in the intermediate host is aided by both antigen switching to evade immune 
killing and by specific attributes of the bradyzoite-specific SAG/SRS gene family 
members (i.e., SRS9 and SAG2CDXY). It has been further speculated that SAG/SRS 
switching during stage transition serves to prepare the parasites for invasion of new cell 
types, which is an appealing concept given the vast array of host animals and tissues that 
T. gondii might encounter during its complex life cycle. 
2.8. Role of surface antigens 
The functional role of these surface antigens has not been clearly defined.  
However, there is evidence to suggest that the SAG proteins are involved in host cell 
attachment, invasion, immune modulation and/or virulence attenuation [22-25].  Multiple 
studies utilizing mAbs or SAG-deficient mutants of T. gondii have implicated a role for 
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various members of this gene family in the process of attachment and invasion of host 
cells, although the results of these studies suggested that each SAG/SRS paralogue might 
function differently in the process [22, 23, 74, 75]. It has been proposed that the 
tachyzoite-specific SAGs are involved in regulation of virulence and elicitation of 
immune response to give rise to an acute infection, while the bradyzoite-specific SAGs 
may be important for immune evasion and persistence of a chronic infection [24, 25].  
In T. gondii, the most abundant and immunogenic, SAG1 has been studied 
multiple times for its potential role in host cell attachment or invasion process. The role 
of SAG1 and SAG2 was studied using SAG mutants as early as in 1980’s. The SAG 
mutants were generated by chemical mutagenesis followed by negative selection made by 
using mAbs against P22 (SAG2A) or P30 (SAG1) in the presence of human complement 
[77, 78]. Although these mutants exhibited minor defects in the process of attachment 
and invasion, however, it was much appreciated that it was possible to isolate P22- and 
P30-negative mutants. This further suggested that that these SAGs play a role in invasion; 
however, these may not be absolutely necessary for the parasite survival. 
Following that, multiple studies followed to study role of SAG1 using antibody 
inhibition assays. 
The antibody inhibition assays using monoclonal or polyclonal antibodies against SAG1 
and/or SAG2 had demonstrated reduced invasion of host cells by tachyzoites [22, 23, 79]. 
With all these studies, it was consistently suggested that SAGs have a role to play in host 
cell attachment and/or invasion, however, the parasites neutralized with monoclonal 
antibody reacting to SAG1, were still able to infect the host cells, which indicated that 
there are other proteins on the parasite surface that complement to mediate attachment 
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and subsequently invasion of the host cells. For the assays using anti-SAG2 mAbs, it was 
shown that the parasites were immobilized on the host cell surface, and subsequently 
resulting in increased invasion [22]. It was further suggested that enhanced internalization 
of immobilized parasites might have been due to either regeneration of SAG2 after 
removing antibody pressure, or phagocytosis by the host cell. 
Later, SAG3 null mutants were generated by replacing the wild-type gene with 
the selectable marker chloramphenicol acetyltransferase [75]. These SAG3 null parasites 
demonstrated a two-fold reduction in their ability to attach to the host cells in vitro, as 
well as decreased virulence when administered in BALB/c mice, when compared to the 
wild type and SAG3-complemented strains. Authors attributed decreased virulence to 
reduced ability of the parasites to invade the host cells. Collectively, the studies suggest 
that SAG3 is one of the T. gondii receptors that act as a ligand in the process of host cell 
attachment. TgSAG3 was further investigated, and it was found that it mediates the 
attachment of T. gondii to cellular heparan sulfate proteoglycans (HSPGs) [52].  The 
authors further corroborated that proteoglycan sulfation was critical for binding of 
TgSAG3 to HSPGs. 
More recently, TgSAG1 and TgSAG2A gene knockout mutants were generated. 
Double gene knockout Δsag1 Δsag2A (DKO) mutant was found to cause an increased 
expression of TgSRS2 [21]. It was also found that overexpression of TgSRS2 had  caused 
attenuation of virulence in mice infected with DKO mutant by 60-70% when compared to 
mice infected with WT strain. Thus, TgSRS2 has been identified as an important negative 
regulator of acute virulence. With this finding it seems that T. gondii has a variety of 
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various positive and/or negative regulatory factors that work in a coordinated fashion to 
modulate virulence. 
In N. caninum, NcSAG1 (Nc-p36) and NcSRS2 (Nc-p43) have been investigated 
for their role in host cell attachment and/or invasion [55, 80]. Polyclonal antiserum 
against N. caninum and mAbs directed against NcSAG1inhibited parasite attachment and 
invasion of the host cells [80]. Nishikawa et al. studied the effect of mAbs reacting 
against NcSAG1 and NcSRS2 on host cell adhesion and invasion. The mAbs used herein, 
were capable of blocking host cell invasion. However, none of these mAbs could inhibit 
parasite attachment to host cells [55]. 
2.9. Surface antigens in S. neurona 
The surface of S. neurona is covered with a related group of GPI – anchored 
proteins referred to as SnSAGs [16, 17, 19] identified based on their orthology to the 
gene family of TgSAGs and SRSs of the related apicomplexan parasite T. gondii [18]. It 
can be speculated that like T. gondii, these surface molecules may be required by the 
parasite for host cell attachment, invasion, immune modulation and/or virulence. A total 
of six SnSAGs have been identified and characterized in S. neurona, and these have been 
designated as SnSAG1-SnSAG6 based on the order of their discovery. However, the 
SnSAGs exhibit antigenic variation i.e. only a subset of these SnSAGs is expressed by 
individual parasite strains [16, 17, 19]. These SnSAGs are abundant in the parasite and 
are highly immunogenic. The immunogenicity of these SnSAGs has been utilized to 
develop sensitive and accurate diagnostic assays. The recombinant forms of the four 
SnSAGs (rSnSAGs), SnSAG1-SnSAG4, were utilized to design antibody capture 
enzyme-linked immunosorbent assays (ELISAs) to diagnose EPM in horses [81, 82]. To 
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further improve sensitivity and specificity, the assays were modified into polyvalent 
assays using rSnSAG2, rSnSAG3, and rSnSAG4 [83].  While all of the polyvalent 
ELISAs gave relatively good results, rSnSAG4/3 gave most accurate and optimum results 
and is now routinely used to detect presence of antibodies against S. neurona in equine 
sera. 
Sarcocystis falcatula is a coccidian parasite that has wide range of intermediate 
hosts that include several orders of birds [84-86]. The life cycle of the parasite is similar 
to the life cycle of S. neurona including the definitive host, the opossum (Didelphis 
virginiana), however, the intermediate hosts for S. falcatula are birds and not the 
mammals [85]. Since S. neurona and S. falcatula utilize opossums as their definitive host, 
S. falcatula was thought to be synonymous to S. neurona [87]. Highly similar orthologs 
to SnSAG2, SnSAG3, and SnSAG4, were amplified and identified in S. falcatula using 
SnSAG specific primers [17]. All these three SAGs shared 95% or greater nucleotide, 
and 85-95% amino acid sequence identity with their counterparts of S. neurona, which is 
consistent with the phylogenetic closeness of the two parasites.  
Surface antigens have also been studied for their genetic diversity, and have been 
found to be extensively variable in their coding regions among S. neurona and S. 
falcatula [17, 19, 88]. Although the group of isolates of S. neurona does not appear to 
share alleles with individuals of S. falcatula, however, multiple polymorphisms were 
identified in SnSAGs. North American strains of S. neurona were compared with the 
isolates of Sarcocystis spp. isolated from South American oppossums of the genus 
Didelphis (Didelphis aurita and Didelphis albiventris) [88]. Upon such comparison  of 
North American strains of S. neurona, with the isolates G37 and G38 isolated from South 
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American oppossums, five polymorphisms were identified at SnSAG2, four at SnSAG3 
and three at SnSAG4 [88]. 
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Figure 2.1: Phylogenetic association of apicomplexan parasites.  
The phylum includes pathogens of medical as well as veterinary importance.  
Toxoplasma gondii, Sarcocystis spp. and Neospora spp. are phylogenetically  
closely associated. 
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Figure 2.2: Life cycle of Sarcocystis neurona.  
Sexual reproduction inside the gut of definitive host (DH), opossum, leads to production 
of sporocysts containing infectious sporozoite stage. Intermediate hosts (IH) get infected 
by ingesting contaminated food/water. Inside IH, parasite undergoes stage conversion 
from sporozoite to merozoite, which is a fast growing stage and is associated with acute 
infection, and then later into bradyzoites, which is a slow growing stage and reside into 
tissue-cysts. 
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Figure 2.3: Cartoon of a zoite showing intracellular organelles.  
The cartoon depicts important specialized organelles that serve as virulence factors in 
apicomplexan parasites. The apicoplast is a remnant of endosymbiont. The apical 
complex includes a conoid, micronemes and rhoptries. Dense granules are scattered in the 
cytoplasm. The parasite surface is covered by an array of surface antigens that are 
speculated to be involved in host cell attachment and/or invasion and immune evasion. 
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Figure: 2.4: Cartoon showing the structure of prototypic SAG1 in Toxoplasma 
gondii.  
SAG1 has a homodimeric configuration with two domains. Domain 1 (D1) is dumble 
shaped and is attached to domain 2 (D2), which is attached to parasite cell membrane by 
GPI anchor.  
Adapted from: He et. al., Nat Struct Biol, (2002). 9(8): 606-611 
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Chapter 3 
Stage-specific expression of the surface antigens (SnSAGs) in  
Sarcocystis neurona 
Published in Veterinary Parasitology (included in dissertation with permission) 
3.1. Chapter Summary 
Sarcocystis neurona is a two-host coccidian parasite whose complex life cycle progresses 
through multiple developmental stages differing at morphological and molecular levels. 
The S. neurona merozoite surface is covered by multiple, related 
glycosylphosphatidylinositol-linked proteins, which are orthologous to the surface 
antigen (SAG)/SAG1-related sequence (SRS) gene family of Toxoplasma gondii. 
Expression of the SAG/SRS proteins in T. gondii and another related parasite Neospora 
caninum is life-cycle stage specific and seems necessary for parasite transmission and 
persistence of infection. In the present study, the expression of S. neurona merozoite 
surface antigens (SnSAGs) was evaluated in the sporozoite and bradyzoite stages. 
Western blot analysis was used to compare SnSAG expression in merozoites versus 
sporozoites, while immunocytochemistry was performed to examine expression of the 
SnSAGs in merozoites versus bradyzoites. These analyses revealed that SnSAG2, 
SnSAG3 and SnSAG4 are expressed in sporozoites, while SnSAG5 was appeared to be 
downregulated in this life cycle stage. In S. neurona bradyzoites, it was found that 
SnSAG2, SnSAG3, SnSAG4 and SnSAG5 were either absent or expression was greatly 
reduced. As shown for T. gondii, stage-specific expression of the SnSAGs may be 
important for the parasite to progress through its developmental stages and complete its 
life cycle successfully. Thus, it is possible that the SAG switching mechanism by these 
 23 
 
parasites could be exploited as a point of intervention. As well, the alterations in surface 
antigen expression during different life cycle stages may need to be considered when 
designing prospective approaches for protective vaccination. 
3.2. Introduction 
The cell surface of S. neurona merozoites is covered with an array of paralogous 
glycosylphosphatidylinositol (GPI)-anchored surface antigens called SnSAGs [16]. These 
surface proteins were identified based on their homology to the gene family of TgSAGs 
and SAG1-related sequences (SRSs) of the related apicomplexan parasite Toxoplasma 
gondii [18]. A total of six SnSAGs have been described in S. neurona, with only a subset 
of these SnSAGs expressed by individual parasite strains [16, 17, 19].  
An extensive search of T. gondii genome using bioinformatic tools has revealed a 
superfamily of 182 SRS proteins [20, 21]. The members of this family belong to either of 
the prototypes, SAG1 or SAG2A [20]. The functional role of these surface antigens has 
not been clearly defined.  However, there is evidence to suggest that the SAG proteins are 
involved in host cell invasion, immune modulation and/or virulence attenuation [22-25].  
Stage-specific expression of the SAG/SRS proteins has been observed in the closely 
related protozoan parasites T. gondii and Neospora caninum [24, 25, 65, 67, 69, 70, 89, 
90].  It has been proposed that the tachyzoite-specific SAGs are involved in regulation of 
virulence and elicitation of immune response to give rise to an acute infection, while the 
bradyzoite-specific SAG molecules may be important for immune evasion and 
persistence of a chronic infection [24, 25].  In the current study, we have examined the S. 
neurona SnSAGs that have been identified in merozoites to determine whether these 
proteins are stage-specific or expressed constitutively. Our analyses demonstrated that 
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these merozoite surface antigens are differentially expressed in the bradyzoite and 
sporozoites stages of S. neurona, which is consistent with the findings for T. gondii and 
N. caninum. 
3.3. Materials and Methods 
Parasites 
Sarcocystis neurona strain SN-138 [91], which is an independent culture derived 
from the SN-37R strain, was maintained in bovine turbinate cells, and extracellular 
merozoites were harvested as described previously [16]. Strain SN-37R sporozoites were 
produced previously in laboratory-reared opossums [92].  Bradyzoites were recovered 
from muscles of a raccoon euthanized 3 months after oral inoculation with strain SN-37R 
sporocysts [92].  Muscle tissue was ground briefly in a blender, and pre-warmed acid-
pepsin solution was added and incubated at 370C for 10 min with shaking, as described 
previously [93].  The muscle homogenate was centrifuged, washed with saline solution, 
centrifuged again, and the supernatant and muscle layer were discarded. 
Primary Antibody 
The primary antibodies against SnSAGs used in the assays were raised in rabbit as 
described earlier [16, 19]. 
Western Blot Analysis 
Merozoites and sporozoites were subjected to lysis in SDS sample buffer 
supplemented with 2-mercaptoethanol and a protease inhibitor cocktail containing 4-(2-
aminoethyl) benzenesulfonyl fluoride, E-64, bestatin, leupeptin, aprotinin, and sodium 
EDTA (Sigma, St. Louis, MO). For sporozoite protein, 1.5 ml of sporocysts [92] in was 
pelleted at 5000 rpm for 15 mins. Pellet was resuspended in 500 µl of sodium dodecyl 
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sulfate (SDS) sample buffer, and homogenized for 2 mins using a Heidolph homogenizer 
(Sigma-Alrich). Proteins were separated on 12% polyacrylamide gels [94], and 
subsequently transferred to nitrocellulose membranes by semi-dry electrophoretic transfer 
in Tris-glycine buffer (pH 8.3). The membranes were blocked for 30 minutes with PBS 
containing 5% non-fat dry milk (NFDM), 5% normal goat serum (NGS), and 0.05% 
Tween 20, followed by primary antibody incubation for 1 h in PBS containing 0.1% 
NGS, 0.1% NFDM, and 0.05% Triton X-114. After multiple washes, the membranes 
were incubated with peroxidase-conjugated, goat anti-rabbit immunoglobulin G 
secondary antibody (Jackson Immunoresearch Labs, Inc.) for 1 h. The membranes were 
then washed and incubated with Supersignal substrate (Pierce, Rockford, IL) for 
chemiluminescence detection, and visualized with a FluorChem 8800 imaging system 
(Alpha Innotech, San Leandro, CA).  
Immunocytochemistry 
For examination of merozoites, culture-derived parasites were harvested and 
diluted in phosphate buffered saline (PBS). A drop of the parasite suspension was 
smeared and air dried on electrostatically treated Superfrost Plus slides (Fisher 
Scientific). The slides were fixed for 10 min in cold acetone kept at -200C, followed by 
washing in deionized H2O (dH2O). For examination of bradyzoites, the organisms 
recovered from raccoon muscle (described above) were smeared on IFA or salinized 
slides and fixed with cold methanol.  The slides were washed in dH2O for 1 min and then 
subjected to heat-induced antigen unmasking by microwave irradiation in 10mM sodium 
citrate buffer, pH 6.0. After allowing cooling at room temperature, the slides were 
washed with PBS-Tween 20 (PBST). Immunocytochemical labeling of parasites was 
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performed using the ImmunoCruz staining system (rabbit: Santa Cruz Biotecnology Inc., 
Santa Cruz, CA) as per the manufacturer’s protocol, with slight modifications. Briefly, 
endogenous peroxidase was quenched by incubating with peroxidase blocking solution 
followed by washing with PBST. Non-specific antigen sites were blocked in rabbit serum 
at RT for 1 h. Primary antibody incubation was carried out for 1 h at room temperature 
(RT) followed by washing with PBST. This was followed by incubation with biotinylated 
secondary antibody for 30 min at RT, followed by washing with PBST. An incubation of 
30 min was performed at RT with horseradish peroxidase (HRP)-streptavidin complex, 
followed by washing with PBST and incubation with HRP substrate for 5 min at RT. 
Slides were counterstained for 1 min with hematoxylin , dehydrated, and covered with a 
glass coverslip using 1-2 drops of permanent mounting medium (Surgipath Medical Ind., 
Inc., Richmond, IL). Normal rabbit serum containing IgG (provided with the kit) served 
as a negative control, while polyclonal antibody raised against the whole S. neurona 
merozoite antigen was used as a positive control. 
3.4. Results 
SnSAG expression in sporozoites 
In order to identify the surface antigens expressed by S. neurona sporozoites, 
Western blot analysis was performed using polyclonal antisera raised against each of the 
merozoite SnSAGs. These analyses revealed SnSAG2, SnSAG3, and SnSAG4 in the 
sporozoites lysate indicating that these proteins are expressed by this stage of S. neurona 
(Figure 3.1).  In contrast, a very minimal amount of SnSAG5 was detected in the 
sporozoite lysate, suggesting that this major surface antigen is down regulated during this 
life cycle stage.  Approximately equal amounts of merozoite and sporozoite antigen were 
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loaded in the gel, as revealed by detection of parasite actin. A weak to moderately 
reactive low mass molecule was observed with the antisera against SnSAG3, SnSAG4, 
and SnSAG5. The identity of these previously unseen bands is unknown. Since the S. 
neurona strain used in this study does not possess the SnSAG1 gene, this paralogue was 
not included in the analysis.   
SnSAG expression in bradyzoites 
To assess SnSAG expression in the bradyzoite stage of S. neurona, 
immunocytochemistry was performed on parasites that had been isolated from tissue 
cysts and applied to slides. As shown in Figure 2.2, culture-derived merozoites and the 
cyst-derived bradyzoites exhibited staining with the positive control antiserum against S. 
neurona whole-merozoite antigen, while no staining of these parasite stages was 
observed with the negative control serum. Polyclonal antisera against SnSAG2, SnSAG3, 
and SnSAG5 intensely labeled the merozoites, while no labeling was observed for the 
bradyzoite stage using these antisera (Figure 3.2). Merozoites labeled inconsistently with 
the anti-SnSAG4 antiserum, which was likely due to the acetone fixation since 
merozoites fixed with glutaraldehyde were efficiently labeled (data not shown), but no 
labeling of bradyzoites was observed with the anti-SnSAG4 antibodies.  Collectively, the 
immunocytochemistry results suggest that the SnSAG2, SnSAG3, SnSAG4 and SnSAG5 
merozoite surface antigens are absent or much less abundant in the bradyzoite stage of S. 
neurona.  As mentioned for the Western blot analyses, SnSAG1 was not examined in 
bradyzoites since this paralogue is not present in the parasite strain used for this study. 
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3.5. Discussion 
Two-host coccidian parasites, which include S. neurona, have complex life cycles 
that require conversion between distinct developmental stages.  Associated with these 
developmental switches are both morphological and molecular alterations that 
differentiate the life cycle stages and permit parasite transmission and survival in a new 
environment.  Documentation of these molecular changes can provide a better 
understanding of the stage conversion process as well as some insights into the function 
of individual proteins or protein families.  The results of the present study demonstrated 
that the SnSAG merozoite surface antigens of S. neurona are expressed in a stage-
specific manner. Specifically, all four of the SnSAGs described in the SN37-R strain (aka 
SN138) were undetectable on bradyzoites by immunocytochemistry, while the SnSAG5 
major surface antigen was mostly absent from sporozoites in Western blot analysis.  
These findings imply that alteration of the parasite surface is important during S. 
neurona’s developmental progression through its major life cycle stages.   
Stage-specific expression of the surface antigens has previously been reported for 
other related Apicomplexan parasites. In T. gondii tachyzoite surface is governed by 
SAG1, SAG2A, SAG3, SRS1, SRS2, SRS3, and several other less highly expressed 
SRSs [70]. Likewise, expression of NcSAG1 and NcSRS2 are found to be tachyzoite 
specific in Neospora caninum [71, 72]. The bradyzoite surface in T. gondii is dominated 
by SAG2C, SAG2CDXY, SRS9, SAG4 and BSR4 [25, 65, 67]. The proteins BAG1, 
SAG4, and BSR4 are specifically expressed at bradyzoite stage in N. caninum [56, 95, 
96]. Stage specific SAG expression in sporozoites has also been observed in T. gondii, 
where ~25 (SporoSAG) and ~67kDa proteins are sporozoite specific [50, 69, 73, 90].  
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It has been speculated that switching of antigens while converting from one 
developmental stage to another serves as a mechanism for parasite persistence, adhesion 
and invasion [24, 25, 50, 97]. Reduced binding of TgSAG1 mutants with the host cells 
was observed in a study, suggesting an important role of this antigen to play in host cell 
adhesion [23]. In a study, TgSAG3 null mutants showed reduced ability to adhere and 
invade the host cells, suggesting a role of this antigen in host cell adhesion and invasion 
process [75]. Furthermore, a cluster of four surface antigens TgSAG2CDXY, subset of 
TgSAG2 subfamily, have been found to be crucial for the persistence of cysts in the brain 
[25]. In a study, expression of SporoSAG in T. gondii tachyzoites imparted enhanced 
invasive property to the transgenic parasites, where authors speculated that this was 
potentially due to higher adhesion of transgenic parasites than parental parasites 
suggesting a role of this protein in the transmission of oocysts/ sporozoite to susceptible 
hosts [69]. Furthermore, it has also been suggested that specific surface antigen 
expression in different developmental stages could be due to different tissue tropism. For 
example, bradyzoites would need the SAGs different from merozoites, required for 
invasion of intestinal epithelium and other tissues of predilection [18, 50, 73, 89, 97]. 
In conclusion, it appears that surface antigen switching during developmental 
stage conversion is conserved in the two-host coccidia and is presumably important for 
successful completion of the parasite life cycle.  Therefore, it is conceivable that stage-
specific SAG/SRS expression and surface antigen switching could be exploited for 
intervention of infection.  In the case of S. neurona infection in horses, it remains 
uncertain whether the parasite normally converts to the bradyzoite stage, so identification 
of bradyzoite-specific SnSAG paralogues may shed light on this question.  As well, it is 
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clear that sporozoites of S. neurona are the only stage capable of infecting horses.  Thus, 
it will be likely important to consider the array of SnSAGs expressed during the 
sporozoite stage if developing a vaccine that is intended to block parasite invasion in the 
equine gut. 
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Figure 3.1: Western blot analysis of S. neurona merozoites and sporozoites revealed 
SnSAG expression in the two life cycle stages.  
The analyses demonstrated that SnSAG2, SnSAG3, and SnSAG4 are present in 
merozoites and sporozoites (arrows), while SnSAG5 expression appears to be 
significantly reduced in the sporozoite stage (arrow with a circle). Actin served as a 
control for protein loading (block arrow). A weak to moderately reactive low mass 
molecule was observed with the antisera against SnSAG3, SnSAG4, and SnSAG5. 
The identity of these previously unseen bands is unknown. Membranes were incubated 
with rabbit polyclonal antisera against parasite actin (1:5000), SnSAG2 (1:10,000), 
SnSAG3 (1: 10,000), SnSAG4 (1:5000) and SnSAG5 (1:5000).  M = merozoite, S = 
sporozoite.  
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Figure 3.2: Immunocytochemical labeling of S. neurona merozoites and bradyzoites 
demonstrated that the SnSAG merozoite surface proteins are downregulated in the 
bradyzoite stage.  
Both merozoites and bradyzoites were labeled with the positive control serum, while 
labeling with α-SnSAG2, α-SnSAG3, α-SnSAG4 and α-SnSAG5 was only apparent in 
merozoites.  Rabbit primary antisera were against whole S. neurona merozoite lysate 
(positive control), SnSAG2, SnSAG3, SnSAG4, and SnSAG5 (1: 1500 dilutions). 
Normal rabbit serum was used as the negative control.  
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Chapter 4 
Identification of new SnSAG/SRS genes in Sarcocystis neurona genome 
4.1. Chapter Summary 
The surface of S. neurona merozoite is decorated by glycosylphosphatidylinositol 
(GPI)-anchored surface antigens called SnSAGs that are homologous to the gene family 
of SAGs and SAG1-related sequences (SRSs) in the related parasite Toxoplasma gondii 
and Neospora caninum. There are a total of six SnSAGs described in S. neurona, while 
there are 182 SAG/SRS proteins in T. gondii and 279 SAG/SRS proteins in N. caninum. 
The present study was conducted in order to determine the exact size of the SRS 
superfamily in S. neurona. Bioinfomatic analyses were conducted in the draft sequence of 
S. neurona genome database using SnSAGs, TgSAGs and NcSAGs as query sequences. 
Antisera were raised against the recombinant protein of two of the newly identified 
SnSAGs. Detailed characterization was performed using the antiserum raised against the 
two new SnSAGs. With the bioinfomatic analyses, there are a total of sixteen new 
SAG/SRS proteins identified in S. neurona genome. Characterization of newly identified 
SnSAG7, a merozoite SnSAG, revealed that it is expressed by merozoites in all stages of 
development, present in most of S. neurona strains, and is expressed by sporozoite life 
cycle stage of S. neurona as well. Characterization of newly identified SnSAG8 
demonstrated that it is present in most of S. neurona strains, and is expressed by the 
bradyzoite life cycle stage. SnSAG8 was not detected in either merozoite or sporozoite 
stages.  
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4.2. Introduction 
The cell surface of S. neurona merozoites is covered with an array of paralogous 
glycosylphosphatidylinositol (GPI)-anchored surface antigens called SnSAGs [16]. These 
surface proteins were identified based on their homology to the gene family of TgSAGs 
and SAG1-related sequences (SRSs) in the related parasite Toxoplasma gondii [18].  The 
functional role of these surface antigens has not been clearly defined. However, the 
studies suggest that the SAG proteins are involved in host cell attachment, invasion, 
immune modulation and/or virulence attenuation [22-25].  Multiple studies utilizing 
mAbs or SAG-deficient mutants of T. gondii have implicated a role for various members 
of this gene family in the process of attachment and invasion of host cells, although the 
results of these studies suggested that each SAG/SRS paralogue might function 
differently in the process [22, 23, 74, 75]. It has been proposed that the tachyzoite-
specific SAGs are involved in regulation of virulence and elicitation of immune response 
to give rise to an acute infection, while the bradyzoite-specific SAGs may be important 
for immune evasion and persistence of a chronic infection [24, 25].  
A total of six SnSAGs have been described in S. neurona, with only a subset of 
these SnSAGs expressed by individual parasite strains [16, 17, 19].  Searches of the 
parasite genome have revealed a superfamily of 182 SAG/SRS proteins in T. gondii [20, 
21], whereas a superfamily of 279 SAG/SRS proteins in Neospora caninum [53]. In S. 
neurona, the exact size of the SRS gene repertoire is not known. The present study was 
conducted to determine the size of the SRS family in S. neurona. With the bioinformatic 
approaches, we have identified sixteen new SAG/SRS proteins in the draft sequence of S. 
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neurona genome, out of which two, SnSAG7 and SnSAG8 have been characterized in 
detail.  
4.3. Materials and Methods 
Sequence identification and annotation of the SAG1-related sequence gene family  
The S. neurona genome was sequenced using a combination of Roche 454 
pyrosequencing of genomic DNA and traditional Sanger sequencing of paired ends from 
fosmid clones of a S. neurona genomic DNA library. Approximately 29X coverage were 
achieved for the S. neurona genome thus sequenced. The S. neurona genome sequence 
was assembled into 3193 contigs that come together into 172 scaffolds and suggests an 
approximate genome size of 124 Mb.  RNA sequence database was generated from S. 
neurona extracellular merozoites and intracellular schizonts using Roche 454 and 
Illumina sequencing platforms. A de novo assembly was generated from the RNA 
sequence database using the CLC Genomics Workbench, version 7.0 (CLC Bio, Boston, 
USA).  The de novo assembly, thus, created was converted into transcriptome database 
using CLC Genomics Workbench, version 7.0. Using SnSAGs as query sequences, the 
transcriptome database was searched to find transcripts for potential SnSAGs. 
Multiple searches were done in S. neurona raw genome database to identify SRS 
paralogues. SnSAGs and SnSAG orthologues in T. gondii and N. caninum were used as 
query sequences to perform searches using Basic Local Alignment Search Tool (BLAST) 
accessible via the S. neurona genome database website (www.sarcodb.org). Initial 
identification of putative SnSAGs/SRSs was made by TBLASTN analyses of the S. 
neurona version 1.0 (release date August 11, 29010) genome database using the query 
sequences of SnSAGs, TgSAGs and NcSAGs. Putative SAG/SRS sequences with 
 36 
 
similarity to SRS proteins were selected based on an e-score cut-off of <10-2. All the 
DNA sequences thus assembled were subjected to manual curation. DNA sequences were 
assessed for the presence of the characteristic features of SRS fold: an N-terminal signal 
peptide, C-terminal GPI-addition sequences; 12 (SAG-1like), four or eight (SAG2A-like) 
conserved cysteine residues, and conserved amino acid sequences of proline and 
tryptophan. Sequences meeting these criteria were assembled into FASTA files and were 
subjected to alignment with the SAGs using CLUSTALW program. Upon alignment, the 
sequences were analyzed for aligned cysteine sequences. 
 Open reading frames for the putative SnSAGs/SRSs were identified based on 
either full or partial transcripts available in the draft sequence of S. neurona 
transcriptome. For SnSAG7, intron was identified by aligning the sequence with the 
transcript available in the draft sequence of S. neurona transcriptome. For SnSAG8, the 
intron was identified based on the sequence similarity to S. muris SAG. 
Western Blot Analysis 
Merozoites and sporozoites were subjected to lysis in SDS sample buffer 
supplemented with 2-mercaptoethanol and a protease inhibitor cocktail containing 4-(2-
aminoethyl) benzenesulfonyl fluoride, E-64, bestatin, leupeptin, aprotinin, and sodium 
EDTA (Sigma, St. Louis, MO). For sporozoite protein, 1.5 ml of sporocysts [92] in was 
pelleted at 5000 rpm for 15 mins. Pellet was resuspended in 500 µl of sodium dodecyl 
sulfate (SDS) sample buffer, and homogenized for 2 mins using a Heidolph homogenizer 
(Sigma-Alrich). Proteins were separated on 12% polyacrylamide gels [94], and 
subsequently transferred to nitrocellulose membranes by semi-dry electrophoretic transfer 
in Tris-glycine buffer (pH 8.3). The membranes were blocked for 30 minutes with PBS 
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containing 5% non-fat dry milk (NFDM), 5% normal goat serum (NGS), and 0.05% 
Tween 20, followed by primary antibody incubation for 1 h in PBS containing 0.1% 
NGS, 0.1% NFDM, and 0.05% Triton X-114. After multiple washes, the membranes 
were incubated with peroxidase-conjugated, goat anti-rabbit/rat immunoglobulin G 
secondary antibody (Jackson Immunoresearch Labs, Inc.) for 1 h. The membranes were 
then washed and incubated with Supersignal substrate (Pierce, Rockford, IL) for 
chemiluminescence detection, and visualized with a FluorChem 8800 imaging system 
(Alpha Innotech, San Leandro, CA).  
Immunocytochemistry 
For examination of merozoites, culture-derived parasites were harvested and 
diluted in phosphate buffered saline (PBS). A drop of the parasite suspension was 
smeared and air dried on electrostatically treated Superfrost Plus slides (Fisher 
Scientific). The slides were fixed for 10 min in cold acetone kept at -200C, followed by 
washing in deionized H2O (dH2O). For examination of bradyzoites, the organisms 
recovered from raccoon muscle were smeared on IFA or salinized slides and fixed with 
cold methanol.  The slides were washed in dH2O for 1 min and then subjected to heat-
induced antigen unmasking by microwave irradiation in 10mM sodium citrate buffer, pH 
6.0. After allowing cooling at room temperature, the slides were washed with PBS-
Tween 20 (PBST). Immunocytochemical labeling of parasites was performed using the 
ImmunoCruz staining system (Santa Cruz Biotecnology Inc., Santa Cruz, CA) as per the 
manufacturer’s protocol, with slight modifications. Briefly, endogenous peroxidase was 
quenched by incubating with peroxidase blocking solution followed by washing with 
PBST. Non-specific antigen sites were blocked in rat serum at RT for 1 h. Primary 
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antibody incubation was carried out for 1 h at room temperature (RT) followed by 
washing with PBST. This was followed by incubation with biotinylated secondary 
antibody for 30 min at RT, followed by washing with PBST. An incubation of 30 min 
was performed at RT with horseradish peroxidase (HRP)-streptavidin complex, followed 
by washing with PBST and incubation with HRP substrate for 5 min at RT. Slides were 
counterstained for 1 min with hematoxylin , dehydrated, and covered with a glass 
coverslip using 1-2 drops of permanent mounting medium (Surgipath Medical Ind., Inc., 
Richmond, IL). Normal rat serum containing IgG served as a negative control.  
Recombinant antigen expression and generation of polyclonal antisera for SnSAG7 
 Amino-terminal domain 1 of predicted mature SnSAG7 (SnSAG7.D1) open 
reading frame, without its predicted amino-terminal signal peptide, was amplified by 
PCR. Restriction enzyme’s sites were incorporated by using primers with a 5’ end NdeI 
restriction site and a 3′ end XhoI restriction site. The SnSAG7 thus amplified, was 
digested with NdeI and XhoI and ligated into NdeI/XhoI digested expression vector 
pET22b (Novagen). The resulting plasmid constructs were transformed into E. coli DH5α 
cells for propagation. The plasmid constructs were screened by restriction enzymes 
digestion, and were sequenced to confirm amplification fidelity. The expression plasmids 
thus selected, were transformed into E. coli BL21-CodonPlus cells (Stratagene), and the 
expression clones expressing high levels of recombinant proteins were selected for 
further use. Protein purification of histidine-tagged recombinant SnSAGs was done using 
cobalt-column chromatography as per the manufacturer’s protocol (Thermo Scientific). 
The purified recombinant protein was used to immunize rabbit and raise monospecific 
polyclonal antisera against SnSAG7 (Cocalico Biologicals Inc.). 
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 Carboxyl-terminal domain 2 of predicted mature SnSAG7 (SnSAG7.D2) open 
reading frame, without its predicted GPI anchor was amplified by PCR, recombinant 
protein was expressed and purified as described above. Full-length predicted mature 
SnSAG7 was amplified from cDNA library of S. neurona (SN3) using the forward primer 
of SnSAG7.D1and reverse primer of SnSAG7.D2. The amplified SnSAG7 was then 
cloned and recombinant protein was expressed and purified as described above. The 
recombinant proteins for SnSAG7.D2 and full length SnSAG7 were used to perform 
ELISA. 
Recombinant antigen expression and generation of polyclonal antisera for SnSAG8 
 For SnSAG8, an expression construct was created by fusing the two individual 
domains of the SnSAG. Amino-terminal domain 1 and carboxyl-terminal domain 2 of 
mature SnSAG8 open reading frame, without its predicted amino-terminal signal peptide 
and carboxyl-terminal GPI anchor, were amplified by PCR. Restriction enzyme’s sites 
were incorporated by using primers with either an NdeI or HindIII or XhoI restriction site 
as shown in Figure 4.1. The amplified domains were digested with the appropriate 
enzymes and ligated together. Full length SnSAG8 was amplified using the ligation mix 
(containing Domain 1 and Domain 2 ligated together) as template DNA, using forward 
primer of Domain 1 and reverse primer of Domain 2. Full length SnSAG8 thus amplified, 
was digested with NdeI and XhoI and ligated into NdeI/XhoI digested expression vector 
pET22b (Novagen). The plasmid constructs were transformed into E. coli DH5α cells for 
propagation. The resulting plasmid constructs were screened by restriction enzymes 
digestion, and were sequenced to confirm amplification fidelity. The expression plasmids 
thus selected, were transformed into E. coli BL21-CodonPlus cells (Stratagene), and the 
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expression clones expressing high levels of recombinant proteins were selected for 
further use. Protein purification of histidine-tagged recombinant SnSAG8 was done using 
Nickel-column chromatography as per the manufacturer’s protocol (Pierce, Thermo 
Fisher Scientific, Inc.). The purified recombinant protein was used to immunize rat and 
raise monospecific polyclonal antisera against SnSAG8 (Cocalico Biologicals Inc.). 
Indirect immunofluorescence assay of extracellular and intracellular merozoites 
For examination of merozoites, culture-derived parasites were harvested and 
diluted in phosphate buffered saline (PBS). A drop of the parasite suspension was 
smeared and air dried on electrostatically treated Superfrost Plus slides (Fisher 
Scientific). For analysis of intracellular parasites, bovine turbinate host cells were grown 
on coverslips and inoculated with 0.8–1.0×105 freshly harvested merozoites. 
Slides/coverslips were fixed for 15 min at 4°C in 2.5% formalin-PBS containing 0.25% 
glutaraldehyde. The cells were permeabilized by treating with 0.2% TX-100/PBS for 30 
min. Blocking was done for 30 min with 10% NGS/PBS, followed by incubation for 1 h 
at room temperature with primary antibody. Slides/coverslips were rinsed and incubated 
with goat anti-rabbit IgG or goat anti-rat IgG conjugated to fluorescein isothiocyanate 
(FITC) or Texas Red (Jackson ImmunoResearch Laboratories) at a 1:200 dilution. The 
slides/coverslips were mounted in Vectashield® Mounting Medium with DAPI (Vector 
Laboratories, Inc.) and examined with a Zeiss axioscope (Carl Zeiss) equipped for phase 
contrast and epifluorescence microscopy. 
Enzyme linked immunosorbent assay 
Concentration of rSnSAG7 was optimized by running titrations of the purified 
recombinant protein and testing and comparing reactivity with a positive and a negative 
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equine serum. Concentration of rSnSAG2 and rSnSAG4/3 were used as described earlier 
[81, 83]. Fifty-microliter of purified recombinant antigen, diluted in PBS to the pre-
determined optimal concentration were added to Corning high-binding, 96-well plates 
and incubated overnight at 4 °C. The following day, the antigen was removed and the 
plates were washed three times with PBS–0.05% Tween 20 (PBST). Blocking was done 
by incubating the wells with 200 μl PBS containing 1.0% Tween 20, 5% NGS, and 
0.01 g/ml nonfat dry milk for 1.5 h at room temperature (RT). The wells were washed 
once, and primary sera were diluted to 1:250 with antibody diluent (1:10 mix of block 
solution with PBST). Fifty-microliter aliquots of the sample dilution were added to 
duplicate wells and the plate was incubated for 1 h at 37 °C. The wells were washed five 
times with PBST, followed by 1 h incubation at 37 °C with 50 μl of HRP-conjugated goat 
anti-horse IgG diluted to 1:10,000 with antibody diluent. The wells were washed five 
times again, 50 μl of the chromagenic substrate TMB (3,3′,5,5′,-tetramethylbenzidine; 
Pierce, Thermo Fisher Scientific, Inc.) was added to each well, and color was allowed to 
develop as desired at RT. Fifty-microliter of 2 M sulfuric acid was added to the wells to 
stop the reaction, optical density (OD) was measured at 450 nm in an Emax microplate 
reader (Molecular Devices).  
Triton-114 phase partitioning of surface antigen 
Triton-114 (TX-114) phase partitioning was performed using the method reported 
by Brusca et al. [98]. Harvested parasites were resuspended in PBS supplemented with 
protease inhibitors and EGTA. Two hundred-microliter of 10% solution of TX-114 in 
PBS was added to the resuspended parasite lysate and incubated for 1 h on ice. The 
suspension was then centrifuged for 10 min at 4 °C, 14000 rpm, the pellet/insoluble 
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fraction was discarded, and the supernatant was incubated for 10 min at 37 °C to achieve 
phase partitioning. The mixture was centrifuged for 10 min at RT, 14000 g, and the upper 
aqueous (AP) and lower detergent phase (DP) were collected carefully. The AP was 
further purified two more times by TX-114 described as above, discarding the pellet each 
time. The DP was washed with PBS and subjected to phase partitioning three more times. 
Proteins in AP and DP were harvested by acetone precipitation by adding two volumes of 
acetone and incubating for 1 h at -20 °C. Three-microliter of each fraction was loaded 
onto SDS-PAGE gel and western blot was performed as described earlier. 
4.4. Results 
Bioinformatic search of new putative SnSAGs/SRSs 
To discover putative SAG/SRS homologs, S. neurona genome database was 
subjected to multiple BLAST searches using SAG/SRS proteins of S. neurona, T. gondii, 
and N. caninum. As a result of the searches, a database of all non-overlapping, putative 
SRS DNA sequences with an e score of <10-2 was assembled, and the sequences were 
curated manually. The DNA sequences that qualified for the characteristics of SRS fold 
were classified as putative paralogues of SnSAGs. Such an approach has resulted into 
identification of 16 new potential SnSAG/SRS proteins. Out of sixteen, six qualified for 
traditional looking SAGs, whereas the rest of ten SAGs were longer than the traditional 
SAGs and possessed conserved SAG domain(s). Three of the new non-traditional 
SnSAGs, New_5, New_6/9 and New_15/16 had multiple conserved SAG domains. 
BLAST searches using the DNA sequences on NCBI revealed five conserved SAG 
domains in New_5 (2kb), seven in New_6/9 (10.7kb) and four in New_15/16 (3.5kb). 
DNA sequences of New_5 shared 23-34% sequence identity with various SRS domain 
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containing proteins or SRS proteins of N. caninum and T. gondii. DNA sequences of 
New_6/9 showed 28% identity to TgSRS44, while New_15/16 shared 27% identity with 
98% coverage for each of them. TgSRS44 is about 2400 amino acids long and has eleven 
conserved SAG domains.  
Genome location was also identified for SnSAGs previously identified and 
characterized i.e. SnSAG1, SnSAG2, SnSAG3, and SnSAG4. The new putative SnSAGs 
thus identified herein, together with SnSAGs previously identified were depicted on their 
respective scaffolds in a schematic diagram (Figure 4.2). SnSAG1, SnSAG5 and 
SnSAG6 are mutually exclusive [17, 19], hence, SN3 expresses SnSAG1 and not the 
other two. Since, the genome data was generated for SN3 strain, location of SnSAG1was 
identified in S. neurona genome.  
Characterization of SnSAGs 
Specific reagents such as recombinant protein and polyclonal antisera were 
generated to characterize the protein encoded by the SnSAG7 gene. The native protein 
SnSAG7 in SN3 merozoite lysate migrated at approximately 32 kDa as evident with the 
western blot done using the polyclonal antiserum raised against rSnSAG7 (Figure 4.3), 
although the predicted molecular weight of the peptide sequence of mature protein is 
26.11 kDa. This aberrant pattern of migration of SnSAG7 is consistent with migration 
pattern observed for other SnSAGs as well as SAG proteins of other coccidians [16, 19, 
99-101]. To confirm that SnSAG7 is a membrane protein, SN3 merozoite lysate was 
subjected to TX-114 partitioning, which separates membrane proteins into a detergent 
phase and soluble proteins into an aqueous phase. Western blot performed using the 
fractionated proteins showed SnSAG7 in the detergent phase, confirming that it is a 
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membrane protein. The control protein SnSAG2 was also detected in the detergent phase 
(Figure 4.3).  
Expression of SnSAG7 during endopolygeny and its distribution in the maturing 
schizonts was determined by performing indirect immunofluorescence using intracellular 
parasites. With the analysis, it was revealed that SnSAG7 is present at all stages i.e. early, 
mid and late stages of endopolygeny, and is uniformly distributed (Figure 4.4). 
Immunofluorescence assays were also done to see distribution of SnSAG7 in 
extracellular merozoites, and the assay demonstrated that the protein is uniformly 
distributed on the individual merozoites (arrows). However, the protein SnSAG7 
appeared to concentrate little more towards the apical end of the extracellular merozoites 
(asterisks). SnSAG7 was also covisualized with SnSAG1, the analysis revealed that 
SnSAG7 share about the similar location as SnSAG1 in the intracellular developmental 
stages of S. neurona. 
Expression of SnSAG7 was examined in two more S. neurona isolates. Western 
blot analysis revealed that apart from SN3 strain, SnSAG7 is expressed by SN4 and 
SN138 strains as well (Figure 4.5). Further, other S. neurona isolates were tested to 
determine the genetic basis of SnSAG7. SnSAG7-specific primers were used to amplify 
the gene locus from genomic DNA of selected parasite strains. The amplification 
products were produced from SN3, SN4, SN-138, SN-OT1, SN-MuCAT2, and SnUT1 
(Figure 4.6). However, no amplification was seen from the strains SN6 and SNMu-1, 
implying that this gene is not present in these strains of S. neurona. Its absence in SN7 
strain, however, cannot be confirmed as SnSAG3 couldn’t be amplified from SN7 strain, 
making the DNA quality questionable. 
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Expression of SnSAG7 was tested in sporozoite stage. Western blot analysis 
demonstrated that SnSAG7 is expressed by merozoites as well as sporozoites (Figure 
4.7). Probing with α-Actin confirmed that parasite antigen was loaded in fairly equal 
amounts. 
The recombinant protein rSnSAG7 was used to conduct ELISA to see 
reactivity of EPM positive horse sera samples versus EPM negative horse sera sample 
to rSnSAG7. A total of ten EPM positive horse sera samples were included to test in 
the assay, and comparisons were made based on OD values achieved towards 
reactivity to rSnSAG7 D1, rSnSAG7 D2, rSnSAG7 D1+ rSnSAG7 D2, full length 
rSnSAG7, rSnSAG2 and rSnSAG4/3 (data not shown for SnSAG7 D1, D2, and 
D1+D2). Reactivity of rSnSAG7 D1 and D2 used either individually or in 
combination, was mostly lower than the reactivity of recombinant antigen of full 
length SnSAG7 (data not shown). rSnSAG7 was recognized by EPM positive horse 
sera samples fairly well (Figure 4.8), but, not as impressive as rSnSAG2 and 
rSnSAG4/3. In general, the recombinant antigens rSnSAG2, rSnSAG4/3, and 
rSnSAG7 all together reacted differently to horse sera samples, however, reactivity of 
these three recombinant antigens was mostly greater than the reactivity of rSnSAG7 
D1 and D2 used either individually or in combination for the given horse sera samples. 
Characterization of SnSAG8 
Upon doing bioinformatic analyses, no clear evidence for true transcript was 
found in the transcriptome data for SnSAG8. However, the DNA sequence qualified 
for all the characteristics of a typical SAG/ SRS protein, including a signal peptide and 
GPI anchor addition sequences. Since, the genome database was generated for 
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merozoite stage of S. neurona, hence, it was hypothesized that this new potential 
SnSAG might be expressed by either sporozoite or bradyzoite stages of the parasite.  
Specific reagents such as recombinant protein and polyclonal antisera were 
generated to characterize the protein encoded by the SnSAG8 gene. The recombinant 
protein SnSAG8 migrated at approximately 32 kDa as evident with the western blot 
done using the polyclonal antiserum raised against rSnSAG8 (Figure 4.10), although 
the predicted molecular weight of the peptide sequence of mature protein is 27 kDa. 
Again, migration of SnSAG8 under reduced conditions is consistent with migration 
pattern observed for SnSAG7 (present study) as well as other SnSAGs and SAG 
proteins of other coccidians [16, 19, 99-101].  
To determine the presence of SnSAG8 in various S. neurona isolates, the gene 
was amplified by PCR. SnSAG8-specific primers were used to amplify the gene locus 
from genomic DNA of selected parasite strains. The amplification products were 
produced from SN3, SN4, SN6, SN138, SN-MU1, SN-OT1, SN-MUCAT2, and SN-
UT1 (Figure 4.9). However, no amplification was seen from SN7 strain of S. neurona. 
Its absence in SN7 strain cannot be confirmed as SnSAG3 couldn’t be amplified from 
SN7 strain, making the DNA quality questionable. 
Expression of SnSAG8 was tested in sporozoite stage by western blot. As this 
SnSAG is not expressed by merozoite stage, recombinant SnSAG8 was used as positive 
control for western blot analysis. Western blot analysis did not detect SnSAG8 in 
sporozoites (Figure 4.10). This data suggests that SnSAG8 is either not expressed by 
sporozoites or it is downregulated to undetectable levels using WB.  
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Expression of SnSAG8 was further tested in bradyzoite life-cycle stage by 
immunocytochemistry, and the immunostaining was compared with the staining 
achieved in merozoite stage of S. neurona. For immunocytochemical assay, normal 
rabbit serum was used as a negative control. Antiserum against SnSAG2 was used as a 
positive control to stain merozoite stage; however, α-SnSAG2 did not stain the 
bradyzoites as observed earlier [102]. Interestingly, polyclonal antiserum raised 
against SnSAG8 labelled the bradyzoites and not merozoites (Figure 4.11). These 
findings demonstrated that SnSAG8 is expressed by bradyzoites.  
4.5. Discussion 
 Bioinformatic analysis of the S. neurona genome database revealed sixteen new 
SAG/SRS proteins of the SRS family of related surface antigens. Collectively, the newly 
found SAG/SRS proteins, together with the six previously identified SnSAGs, we now 
have a SRS family of 22 SnSAGs. However, since SnSAGs exhibit antigenic variation, 
not all are present in all S. neurona strains. The size of the SRS family in S. neurona is 
much smaller as compared to much larger size of SRS superfamily of 182 SRS sequences 
in T. gondii and 279 in N. caninum [21, 53]. The evolutionary advantage of such an 
expanded family is unknown. However, there were speculations that larger size of SRS 
repertoires in T. gondii may serve to accommodate the broad spectrum of host range [20] 
of the parasite. The reverse hypothesis was made when much larger sized superfamily of 
NcSAGs was revealed in N. caninum that has narrower host range than T. gondii [53]. 
The S. neurona has much narrower host range than T. gondii and N. caninum, and the 
present study demonstrates that there are a total of 22 SnSAGs/SRSs in S. neurona. Thus, 
it is possible that potentially there is no correlation between the number of SAG/SRS 
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proteins and host range. It is therefore, remains unclear that what account for the number 
of SAGs/SRSs possessed by these coccidians. Although, the present study has extended 
the number of SRS genes in S. neurona, it is presently not known if they are expressed in 
a stage-specific manner. Trancriptome evidence for the SRS genes identified suggests that 
mostly are expressed at least in merozoite stage. It seems that the SAGs/SRSs that are not 
expressed in merozoite stage may be more important in other stages of the life cycle. 
 The location of SnSAGs/SRSs was roughly mapped onto the scaffolds (Figure 
4.2). The gene mapping revealed that all the SRS genes were located at different scaffolds 
and at separate loci, which is fairly consistent with the findings for NcSAGs [53]. In T. 
gondii as well, there are frequently multiple genes expressed in tandemly arrayed fashion 
[20]. In S. neurona, it is noteworthy that seven of the 22 SnSAGs/SRSs genes were 
tandemly arrayed on scaffold 4, with the intergenic distances ranging from ~1.2 kb to 
~2Mb. This finding is consistent with the pattern seen for SAG/SRS genes in T. gondii. 
Gene duplication seems to be responsible for such a tandemly-arrayed multigene cluster. 
Also there were three SAG/SRS genes identified in the S. neurona genome that possess 
more than typical two conserved SAG domains. New SAG/SRS ‘New_5’ has five 
conserved SAG domains; ‘New_6/9’ has seven conserved SAG domains, while 
‘New_15/16’ has four conserved SAG domains. These types of SAGs with multiple 
SAG/SRS domains have been identified in T. gondii as well as N. caninum genome [20, 
21, 53]. However, the significance of presence of such multiple domains is still not 
known.  
 The distribution of SnSAG7 during intracellular development as well as in 
extracellular merozoites is consistent with other SnSAGs [16], which suggests that it 
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perhaps contributes in the function of SnSAGs for initial interactions with the host cells. 
Non-expression of SnSAG7 in some strains (SN6, SN7 (?), and SN-Mu1) is not 
surprising. Antigenic diversity has been well documented in S. neurona isolates [19, 103, 
104]. Since, SnSAG1, SnSAG5 and SnSAG6 are mutually exclusive [17, 19], it is 
possible that the strains not possessing SnSAG7 may express an alternate paralogue, 
which is mutually exclusive to SnSAG7. Characterizing other newly found 
SnSAGs/SRSs from the present study and testing their genetic basis in these given strains 
may provide some insight into this. The reactivity of α-SnSAG7 antiserum appeared 
lower in merozoite antigen than sporozoites antigen. It is fairly suggestive that expression 
of SnSAG7 may be upregulated in sporozoites than in merozoites; however, it cannot be 
concluded based on non-quantitative test such as western blot. Nevertheless, this finding 
of differences in reactivity in the two stages may account for higher concentration of 
antiserum used in WB using merozoite antigens as compared to other SnSAGs. There 
were discrepancies in the reactivity of rSnSAG7 in ELISA when compared to the 
reactivity of rSnSAG2 and rSnSAG4/3. Immunodominant SnSAG1 has been found to be 
absent in some S. neurona strains, which has accounted for relatively poor accuracy in 
assays based on the SnSAG1 antigen [81, 105]. Thus, it is conceivable that antigenic 
variation of SnSAG7 may account for the discrepancies in ELISA results.  
 Lack of transcriptome evidence for SnSAG8 suggested that it is not expressed in 
merozoite stage. SnSAG8 was not detected in sporozoite antigen by immunoblotting 
(Figure 4.10). However, it is difficult to conclude that SnSAG8 is not expressed by 
sporozoites since polyclonal antiserum against SnSAG8 reacted poorly to the 
recombinant antigen rSnSAG8 as well. However, bradyzoites were labelled very 
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intensely with α-SnSAG8 polyclonal antiserum. So far, SnSAG8 is the first surface 
antigen identified which is expressed by S. neurona bradyzoites. The recombinant protein 
rSnSAG8 was used to perform ELISA to see reactivity of EPM positive horse sera 
samples versus EPM negative horse sera samples (data not included). The antigen 
rSnSAG8 was seen reacting to some of the EPM positive as well as negative horse sera 
samples with higher ODs. These results are unexpected and inconclusive since the assays 
did not worked appropriately. 
In summary, finding new members of the superfamily of SAGs in S. neurona 
suggests that expression of numerous surface antigens on the parasite surface is 
consistent among heteroxenous coccidia. Furthermore, the present study provides the 
template to address various questions about the superfamily of SnSAGs/SRSs in S. 
neurona that can be addressed experimentally. It would be interesting to know how this 
superfamily of SAGs/SRSs is evolving, how they interact with the host cells, what are 
their cellular ligands, how regulation of stage and strain specific expression takes place 
and contributes towards virulence, pathogenesis, and immune evasion. 
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Table 4.1: Compilation of SnSAG/SRS genes in S. neurona. 
With 16 newly identified SnSAGs, together with 6 previously identified SnSAGs, we 
have a total of 22 SnSAGs in S. neurona 
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Figure 4.1: Cloning strategy for SnSAG8 
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Figure 4.2: Sketch diagram of SnSAGs distributed on different scaffolds. 
Grey boxes show location of SnSAGs, bend arrows show translation start site. The 
diagram shows that some SnSAGs are tandemly arrayed on scaffold. Scaffold 2 and 4 
carry multiple SnSAGs arranged in a tandemly arrayed fashion. 
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Figure 4.3: Triton-114 partitioning indicating that SnSAG7 is membrane associated.  
SnSAG2 detected in detergent phase, was used as a control. Membranes were incubated 
with rabbit polyclonal antisera against SnSAG7 (1:1000) and SnSAG2 (1:10,000). DP = 
detergent phase; AP = aqueous phase. 
 
Figure 4.4: Immunofluorescence assay to see localization of SnSAG7 during 
endopolygeny and extracellular merozoites. 
(A) Labelling was seen in all stages of intracellular development as well as extracellular 
merozoites (arrows). SnSAG7 appeared to be concentrated more towards the apical end 
(asterisks). (B) Co-visualization of SnSAG7 with SnSAG1 revealed that both the surface 
antigens share about the similar location on the parasite surface. Primary antibody 
incubattion was done against SnSAG7 (1:700) and SnSAG1 (1:1000).  
A 
B 
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Figure 4.5: Western blot analysis in S. neurona strains. 
Results revealed that SnSAG7 is expressed in SN3, SN4, and SN-138 strains.  
Membranes were incubated with rabbit polyclonal antisera against SnSAG7 (1:1000).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: PCR amplification of SnSAG7 from various S. neurona strains.  
Results demonstrated that SnSAG7 is present in most of the strains tested.  
SnSAG7 gene was not amplified from SN6, SN7 and SN-MU1.  
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Figure 4.7: Western blot analysis of S. neurona merozoites and sporozoites to see 
expression of SnSAG7.  
The analysis revealed that SnSAG7 is expressed in both the life cycle stages (arrow). 
Actin served as a control for protein loading (block arrow). Membranes were 
incubated with rabbit polyclonal antisera against parasite actin (1:5000) and SnSAG7 
(1:1,000).  M = merozoite, S = sporozoite.  
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Figure 4.8: Enzyme Linked Immunosorbent Assay to see reactivity of SnSAG7 in 
EPM positive horse sera samples.  
Binding ratios were compared by the mean OD450 obtained for the seropositive samples. 
SnSAG7 was recognized by EPM positive horse sera samples SnSAG7 fairly well, but 
not as impressive as SnSAG2 and SnSAG4/3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: PCR amplification of SnSAG8 from various S. neurona strains.  
Results demonstrated that SnSAG8 is present in most of the strains tested.  
SnSAG8 was not amplified from SN7. 
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Figure 4.10: Western blot analysis of S. neurona sporozoites to see expression of 
SnSAG8.  
SnSAG8 was not detected in sporozoites suggesting that SnSAG8 is not expressed in 
the sporozoite stage of S. neurona. Actin served as a control for protein loading.  
 
Figure 4.11: Immunocytochemical labeling of S. neurona merozoites and 
bradyzoites demonstrated that SnSAG8 is expressed in the bradyzoite stage.  
Primary antisera were against SnSAG2 (rabbit) (1:500) and SnSAG8 (rat) (1: 400). 
Normal rabbit/rat serum was used as the negative control.  
 
 
Copyright © Ablesh Gautam 2014 
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Chapter 5 
Functional characterization of the surface antigens (SnSAGs) in Sarcocystis neurona 
5.1. Chapter Summary 
Sarcocystis neurona is a protozoan parasite that causes the serious neurologic 
disease equine protozoal myeloencephalitis (EPM). The S. neurona merozoite surface is 
covered by multiple related proteins, which are orthologous to the surface antigen (SAG) 
gene family of Toxoplasma gondii. The SAG surface antigens in T. gondii and another 
related parasite Neospora caninum seems necessary for parasite transmission and 
persistence of infection. The present study was conducted to assess the role of SnSAGs in 
host cell attachment and/or invasion by S. neurona. Serum neutralization assays were 
conducted using heat inactivated polyclonal serum raised against SnSAG1, SnSAG2, 
SnSAG3, and SnSAG4. Results obtained from these assays suggest a potential role of 
SnSAG1 and SnSAG4 in host cell attachment and/or invasion. However, results obtained 
for SnSAG2 and SnSAG3 were inconsistent. The information acquired from the present 
study will help to understand the importance of the SnSAG proteins for parasite survival 
and could lead to improved methods for EPM prevention and/or treatment. 
5.2. Introduction 
The cell surface of S. neurona merozoites is covered with an array of paralogous 
glycosylphosphatidylinositol (GPI)-anchored surface antigens called SnSAGs [16]. These 
surface proteins were identified based on their homology to the gene family of TgSAGs 
and SAG1-related sequences (SRSs) in the related parasite Toxoplasma gondii [18].  A 
total of six SnSAGs have been described in S. neurona, with only a subset of these 
SnSAGs expressed by individual parasite strains [16, 17, 19].  Searches of the parasite 
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genome have revealed a superfamily of 182 SAG/SRS proteins in T. gondii [20, 21], 
whereas a superfamily of 279 SAG/SRS proteins in N. caninum [53]. 
The functional role of these surface antigens has not been clearly defined.  
However, there is evidence to suggest that the SAG proteins are involved in host cell 
attachment, invasion, immune modulation and/or virulence attenuation [22-25].  Multiple 
studies utilizing mAbs or SAG-deficient mutants of T. gondii have implicated a role for 
various members of this gene family in the process of attachment and invasion of host 
cells, although the results of these studies suggested that each SAG/SRS paralogue might 
function differently in the process [22, 23, 74, 75]. It has been proposed that the 
tachyzoite-specific SAGs are involved in regulation of virulence and elicitation of 
immune response to give rise to an acute infection, while the bradyzoite-specific SAGs 
may be important for immune evasion and persistence of a chronic infection [24, 25]. In 
the present study, we have examined the role of SnSAGs in host cell attachment and/ or 
invasion. Our studies suggest that SnSAG1 and SnSAG4 might play a role in mediating 
host cell attachment and/or invasion. The findings for SnSAG2 and SnSAG3 were 
inconsistent. 
5.3. Materials and Methods 
Parasite cultures 
Yellow fluorescent protein (YFP) expressing parasites derived from SN3 strain 
(Sn-YFP) were used in this study [106]. Merozoites of S. neurona were maintained by 
serial passage in bovine turbinate (BT) cells, and extracellular merozoites were harvested 
as described previously [107]. Upon disruption of the BT host cell monolayer, Sn-YFP 
merozoites were passed through 22 G and 25 G needles and purified from the cell debris 
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by 3.0 μm Nucleopore® (Whatman) membrane. The harvested parasites were counted 
with a hemocytometer and used fresh for conducting antibody inhibition assays. 
Polyclonal antisera against SnSAGs 
Monospecific polyclonal antisera against the recombinant proteins of SnSAG1, 
SnSAG2, SnSAG3, and SnSAG4 were generated previously by immunization of rabbits 
[16]. Recombinant protein for new merozoite surface antigen SnSAG7 (unpublished 
data) was purified and antiserum was produced by immunization of rabbit as described 
previously [16]. 
Antibody inhibition assay 
Antiserum was heated at 560C for 30 mins to inactivate complement. Sn-YFP 
suspensions (1 x 103 of S. neurona merozoites) were treated with heat-inactivated 
antiserum against either individual SnSAGs or combinations of antiserum against 
SnSAGs. Antisera titration was done using different dilutions. Based on the titration, 4% 
antisera dilution was used in all the experiments. The treated parasites were incubated for 
30 mins at room temperature. Control group of parasites were treated with normal rabbit 
serum. Following incubation, the parasites were added to the confluent monolayers of BT 
cells in a 24 well plate. The parasites were allowed to invade the host cells for 2 hrs at 37 
0C, followed by one washing and then were allowed to grow and form schizonts until day 
4. Individual fluorescent schizonts were counted under fluorescent microscope on day 4. 
The experiments were done in quadruplicates, and were repeated at least three times. The 
results shown are the mean of quadruplicates in a given experiment. Figure 5.1 depicts 
the concept of the antibody inhibition assays. 
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 Statistical analysis was carried out using student’s t-test to compare results and 
their statistical significance between control and test groups. 
5.4. Results 
Treatment of S. neurona merozoites with α-SnSAG polyclonal antibodies 
The ability of rabbit polyclonal antisera against SnSAG1, SnSAG2, SnSAG3, and 
SnSAG4 to block invasion of host cells was evaluated by performing antibody 
neutralization assays. In general, polyclonal antiserum for each SnSAG was able to 
inhibit host cell invasion (Figure 5.2). However, the results varied statistically for 
antiserum raised against individual SnSAGs. As shown in Figure 5.2, polyclonal α -
SnSAG1 reduced invasion up to 49% (P < 0.004), although higher invasion of up to 82% 
was observed in some experiments. Similarly, invasion by the group treated with α-
SnSAG2 was achieved up to 59% (P < 0.006), with higher invasion of up to 93% seen in 
some experiments. Up to 63% (P < 0.02) invasion rate was achieved after treatment with 
α-SnSAG3, although higher invasion of up to 95% was observed with this antiserum in 
some experiments. Invasion rate obtained for the parasite group treated with α -SnSAG4 
was 42%, (P < 0.001); however, higher invasion of up to 85% was achieved with this 
antiserum in some experiments. Although reduced invasion rate was seen consistently for 
all the treatments with α-SnSAG1 through α -SnSAG4, statistical significance was 
consistent for only α-SnSAG1 and α-SnSAG4. 
Invasion assays were also conducted for the newly identified SnSAG7 (see 
chapter IV). Although there was always a drop in invasion rate using α-SnSAG7, 
statistical significance was not achieved (data not shown). The data shown for the 
invasion assays in Figure 5.2 is one of the repeated experiments.  
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 Collectively, the results suggest that SnSAGs may have a potential role in host 
cell invasion. Our data further suggests that specifically SnSAG1 and SnSAG4 may be 
involved in the process of host cell invasion. 
Treatment of S. neurona merozoites with combinations of α-SnSAG polyclonal antibodies 
Invasion assays were also done using combinations of antiserum against SnSAGs. 
Although invasion was reduced with individual α-SnSAG polyclonal antibodies, 
treatment of the parasites with combinations of α-SnSAG polyclonal antibodies gave 
variable and confounding results. There was minimal inhibition of invasion for most of 
the combinations ranging from 1-5%. There was 5% inhibition for α-SnSAG1+2, 1% for 
α-SnSAG1+3, 1% for α-SnSAG2+3, and 4% for α-SnSAG2+4. The other two 
combinations α-SnSAG1+4 and α-SnSAG3+4 had shown an increase in the invasion rate 
by 12% and 8% respectively (Figure 5.3).   
These results suggest that although, antiserum against individual SnSAGs tends to 
reduce host cell invasion, combinations of antiserum against SnSAGs do not seem to 
reduce invasion rate to an appreciable level. On the contrary, an increase in invasion was 
observed for a few combinations of α-SnSAG polyclonal antibodies. 
5.5. Discussion 
Host cell attachment is a prerequisite for microbial colonization and eventually 
for host cell invasion, which is mediated by surface proteins called ‘adhesins’ expressed 
on microbial surface [108, 109]. The adhesins interact with protein or carbohydrate 
epitopes found on host cell surface. In T. gondii, studies suggest that SAGs are associated 
with host cell attachment, invasion immune modulation and/or virulence attenuation [22-
25, 52]. The results from present study further substantiate the speculations about the role 
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of SAGs. The results from present study suggest that SnSAGs are potentially involved in 
host cell invasion. Specifically, polyclonal antisera against SnSAG1 and SnSAG4 were 
capable of inhibiting the parasites to invade the host cells, and this inhibition was found 
to be statistically significant consistently, thus suggesting that SnSAG1 and SnSAG4 are 
important parasite ligands that may be involved in host cell invasion. Although, statistical 
significance was inconsistent for the groups of parasites treated with α-SnSAG2 and α-
SnSAG3 polyclonal antibodies, a reduction in the host cell invasion was observed for 
each experiment. Similarly, when the parasites were treated with α-SnSAG7 polyclonal 
antibodies, the invasion rate was reduced, but was not statistically significant (data not 
shown). For SnSAG7, polyclonal antiserum was raised against domain 1 (see chapter 
IV). Hence, it is possible that this molecule was not efficiently blocked on the parasite 
surface using the antisera raised against the single domain of SnSAG7.  
The combinations of α-SnSAG polyclonal antibodies when used for the assays did 
not seem to reduce invasion to a significant level. Instead, for some combinations, the 
invasion rate was increased when compared to the control group of parasites. An increase 
in invasion was observed by Grimwood and Smith, when they used monoclonal 
antibodies against TgSAG2 to block host cell invasion [110]. It was found that the 
parasites were immobilized on the host cell surface, and resulted in an increased invasion 
[22]. It was further suggested that enhanced internalization of immobilized parasites 
might have been due to either reactivation of SAG2 after removing antibody pressure, or 
phagocytosis by the host cell. The authors favored the latter hypothesis considering 
diminished survival rate of the parasites. Here, in these studies, the parasites were 
counted after they had grown into schizonts, meaning that the parasites had been capable 
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of survival and persistence of infection. Hence, it would be appropriate to favor the 
former hypothesis that α-SnSAG polyclonal antibodies when applied in combinations, 
results in immobilizing the parasites on the host cell surface. When the antibody pressure 
is removed by washing, respective SnSAGs become reactivated, thus, enabling the 
parasite population entering into the host cells, hence, causing an overall increase in 
invasion.  
The results from these invasion assays using α-SnSAG polyclonal antibodies are 
important for SnSAG implications. For any therapeutic or preventive approach such as 
vaccine development, it may not be appropriate to use SnSAGs in combinations. Since 
any α-SnSAG polyclonal antibody treatment could not give 100% inhibition of invasion 
process, the data suggest that there are other surface antigens/ proteins involved in host 
cell invasion. Surface Protein 1 (SnSPR1) is a surface protein of S. neurona merozoites 
that is abundantly expressed on the outer surface of the parasite [111]. Treatment of 
parasites with α-SnSPR1 resulted into 23% inhibition of invasion, suggesting that this 
protein may play a role in host cell attachment and/or invasion [111]. Indeed, alternative 
surface molecules like SnSPR1 would allow the parasite to compensate the loss of 
function of the SnSAG.  Furthermore, It will be interesting to use α-SnSAG monoclonal 
antibodies used in similar assays and see the effects on host cell invasion by the parasites, 
whether mAbs inhibit invasion more efficiently than the polyclonal antiserum. 
Generation of SnSAG-knockout parasites may further provide convincing results in terms 
of role of SnSAGs in host cell attachment and/or invasion. 
In T. gondii, SAG1 has been studied multiple times for its potential role in host 
cell attachment or invasion process. Antibody inhibition assays using monoclonal or 
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polyclonal antibodies against TgSAG1 demonstrated reduced invasion of host cells by 
tachyzoites [79]. However, the parasites treated with α-TgSAG1 antibody were still able 
to infect the host cells, which indicate that there are other proteins on the parasite surface 
that complement to mediate attachment and subsequently invasion of the host cells [79]. 
TgSAG3 was also studied for its role in host cell attachment/ invasion. Tachyzoites of T. 
gondii deficient in SAG3 were found to be less virulent in-vivo than wild-type parasites, 
suggesting that SAG3 may play a role in the persistence of parasite infection [112]. 
Similar results were found in another study investigating the potential role of SAG3 in T. 
gondii, where it was demonstrated that SAG3 null mutants had attenuated infectivity 
causing reduced capacity to attach to the host cells [75]. This suggests that SAG3 is one 
of the T. gondii receptors that act as a ligand in the process of host cell attachment. In N. 
caninum, NcSAG1 (Nc-p36) and NcSRS2 (Nc-p43) have been investigated for their role 
in host cell attachment and/or invasion [55, 80]. Polyclonal antiserum against N. caninum 
and mAbs directed against NcSAG1inhibited parasite attachment and invasion of the host 
cells [80]. Nishikawa et al. studied the effect of mAbs reacting against NcSAG1 and 
NcSRS2 on host cell adhesion and invasion. The mAbs used against NcSAG1 and 
NcSRS2, were capable of blocking host cell invasion. However, none of these mAbs 
could inhibit parasite attachment to host cells [55]. 
In conclusion, the surface antigens play an important role in host-parasite 
interactions. In particular, we now have evidence in apicomplexan parasites that SAGs 
allow the parasites to attach and/or invade the host cells. The results from our studies are 
consistent with previous findings about functional role of SAGs in the apicomplexans. In 
S. neurona, it will be interesting to study the role of other surface antigens in the process 
 67 
 
of host cell invasion. The tachyzoite/merozoite SAGs are believed to be involved majorly 
in virulence and immune response elicitation and bradyzoites SAGs in immune evasion. 
Thus, in S. neurona, it would be interesting to study SnSAGs for their role in 
immunological pathways. Similarly, it would be worth to functionally characterize 
bradyzoite SAG, SnSAG8 (Chapter IV), in terms of its role in immune evasion and 
persistence of a chronic infection. Collectively, the information about the role of SAGs in 
host cell attachment and/or invasion may be exploited to develop therapeutic measures to 
block parasite invasion. 
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Figure 5.1: Model for antibody inhibition of parasite invasion.  
Surface antigens (SAGs) present on the parasite surface are believed to interact with the 
host cell receptors during invasion process. It was speculated that blocking SnSAGs by α-
SnSAGs will make the surface antigens unavailable to interact with host cell receptors, 
thus, diminishing the host cell invasion process. 
Figure 5.2: Inhibitory effect of treatment of S. neurona merozoites with polyclonal 
antibodies on host cell invasion.  
The invasion rate was compared with parasites treated with normal rabbit serum. The 
difference in invasion in α-SnSAG1 and α-SnSAG4 treated versus control was 
statistically significant each time (bigger asterisks). However, the rates obtained with α-
SnSAG2 and α-SnSAG3 treated parasites were lower than the control group, but the 
statistical significance was inconsistent (smaller asterisks). The invasion rates represent a 
representative single experiment and mean of quadruplicates.  
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Figure 5.3: Effect of treatment of S. neurona merozoites with combinations of 
different α-SnSAG polyclonal antibodies on host cell invasion.  
The invasion rate was compared with parasites treated with normal rabbit serum (NRS). 
(A) Effect of treatment with combinations of α-SnSAG1 & α-SnSAG2. (B). Effect of 
treatment with combinations of α-SnSAG1 & α-SnSAG3. (C). Effect of treatment with 
combinations of α-SnSAG1 & α-SnSAG4. (D). Effect of treatment with combinations of 
α-SnSAG2 & α-SnSAG3. (E). Effect of treatment with combinations of α-SnSAG2 & α-
SnSAG4. (F). Effect of treatment with combinations of α-SnSAG3 & α-SnSAG4. These 
results suggest combinations of antiserum against SnSAGs do not seem to reduce 
invasion rate to an appreciable level. On the contrary, an increase in invasion was 
observed for a few combinations of α-SnSAG polyclonal antibodies. The invasion rates 
represent mean of quadruplicates. Experiments were repeated at least three times. 
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Chapter 6 
General Discussion and Summary 
The goal of the present study was to explore the SnSAG gene family of surface 
antigens in S. neurona. The findings from the first part of the present study demonstrate 
that like other related coccidians, the phenomenon of stage-specific expression occurs 
with S. neurona surface antigens as well. Specifically, all four of the SnSAGs described 
in the SN37-R strain (aka SN138) were undetectable on bradyzoites, whereas the 
SnSAG5 major surface antigen was mostly absent from sporozoites. Also, the newly 
identified SnSAG8 was detected in bradyzoites only. These findings imply that alteration 
of the parasite surface is important during developmental progression of S. neurona 
through its major life cycle stages.  Therefore, it is conceivable that knowledge of stage-
specific SAG/SRS expression could be exploited for intervention of infection.  
Sporozoites of S. neurona are the only stage capable of infecting horses.  Thus, it will be 
likely important to consider the array of SnSAGs expressed during the sporozoite stage if 
developing a vaccine that is intended to block parasite invasion in the equine gut.  
It has been speculated that switching of antigens while converting from one 
developmental stage to another serves as a mechanism for parasite persistence, adhesion 
and invasion [24, 25, 50, 97]. Furthermore, it has also been suggested that specific 
surface antigen expression in different developmental stages could be due to different 
tissue tropism. For example, a different set of SAGs may be required by the bradyzoites 
to invade intestinal epithelium or other tissues of predilection [18, 50, 73, 89, 97]. It 
would therefore be interesting to see the phenotypes of the parasites when the timing of 
expression of these is altered. For example, engineering the merozoites to express 
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bradyzoite’s SAG, SnSAG8 (see chapter IV), and see how the parasites survive inside the 
host cells. Since, bradyzoites have to attach and invade different types of host cells than 
merozoites; it would be interesting to see the effect of expression of SnSAG8 on the 
behavior of merozoites in terms of attachment and /or invasion of the host cells. Would 
the expression of SnSAG8 be beneficial or detrimental to the merozoite stage of the 
parasite? In a prior study, expression of SporoSAG (sporozoite SAG) in T. gondii 
tachyzoites imparted enhanced invasive property to the transgenic parasites, where 
authors speculated that this was potentially due to higher adhesion of transgenic parasites 
than parental parasites suggesting a role of this protein in the transmission of oocysts/ 
sporozoite to susceptible hosts [69]. These authors also studied the dynamics of 
developmental gene expression of sporozoite-tachyzoite development. They found that 
sporozoite protein expression starts declining rapidly with the onset of tachyzoite protein 
expression. This further suggest that although, proteins specific to life cycle stages have 
important function to play in the particular stage in which they are expressed, they might 
function differently (possibly detrimental) if expressed in other stages. 
Like merozoites, if we can successfully grow S. neurona bradyzoites in cell 
culture, then it would also be worthwhile testing the expression of merozoite SnSAGs in 
bradyzoites. It will be interesting to see how merozoites SnSAGs, when expressed in 
bradyzoites affect the persistence of latent infection in the form of cysts.  
Toxoplasma gondii infection causes IL-12 secretion by dendritic cells, 
macrophages, and neutrophils, which in turn stimulates IFNγ secretion from T-cells and 
NK cells [113, 114]. IFNγ, thus, produced is an important cytokine to impart resistance to 
both acute and chronic infections caused by T. gondii [115, 116]. Toxoplasma has 
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developed mechanisms to diminish IFNγ signaling and evade immune response [117]. It 
would be interesting to see study the immune responses elicited by S. neurona merozoites 
lacking SnSAG1/SnSAG4 or both versus wild type parasites. Since, SnSAG8 is 
expressed in bradyzoites, thus, it can be hypothesized that SnSAG8 might play an 
important role in immune evasion. Thus, role of SnSAG8 can be investigated in immune 
evasion when expressed in bradyzoites versus expressed in merozoites.  
The present study has further extended the number of SAGs/SRSs genes harbored 
by S. neurona. Although with the present study we can be intuitive about the role of 
SnSAGs, however, the precise role of this superfamily of surface antigens is still not very 
clear. It is also speculated that the array of SRS proteins may act as a protective barrier 
against the external environment [20], however studies will need to be done to test this 
hypothesis.  
The studies suggest that SAG3 is one of the T. gondii receptors that act as a ligand 
in the process of host cell attachment. SAG3 in T. gondii was further investigated, and it 
was found that it mediates the attachment of T. gondii to cellular heparan sulfate 
proteoglycans (HSPGs) [52].  The authors further corroborated that proteoglycan 
sulfation was critical for binding of TgSAG3 to HSPGs. It would be interesting to pursue 
experimental questions about the types of host cell receptors that SnSAGs might interact 
with. Along with the precise cellular ligands, the modes of binding of SnSAG/SRS 
proteins also need to be determined. Understanding the details of these interactions will 
not only provide an insight to understand these mechanisms, it has far-reaching 
implications.  The information, thus, acquired may provide basis for designing 
prophylactic and therapeutic interventions. Furthermore, it is possible that the cellular 
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ligands may render the specific SnSAG/SRS antigens more immunogenic or expose them 
for antigen presentation, thus rendering the surface antigens as adhesins as well as 
immune targets. Two of the SnSAGs, SnSAG1 and SnSAG2 are apparently the most 
immunogenic among all other merozoite SnSAGs [16]. Newly identified merozoite SAG, 
SnSAG7 also doesn’t appear as immunogenic as these two SnSAGs are. Why these two 
antigens are so immunogenic than other SnSAGs is unclear. Do the immunodominant 
SnSAGs function to distract immune responses that may otherwise be elicited by other 
SnSAGs? It would be interesting to see if any other surface antigens among newly 
identified SnSAGs turn out to be as immunogenic as SnSAG1 and SnSAG2.  
The findings obtained from invasion assays clearly suggest that SnSAG1 and 
SnSAG4 contribute in the process of host cell attachment and/or invasion. The results 
further suggest that there are alternate molecules, may be other SnSAGs or other proteins 
that allow the parasite to compensate the loss of function of the SnSAG. It will be 
interesting to use α-SnSAG monoclonal antibodies in similar invasion assays, and see if 
mAbs work in a similar or different way as polyclonal antisera have worked. If parasite 
mutants can be engineered that are deficient in SnSAG1 or SnSAG4, observing their 
phenotype can substantiate the role they might play in the invasion process. Also, double 
gene knockouts of SnSAG1 and SnSAG4 may provide a better insight for the significance 
of these two surface antigens. Since SnSAG1 is highly immunogenic, thus, it would also 
be interesting to see how the parasites lacking SnSAG1 elicit the immune response. 
Surface Protein 1 (SnSPR1) is a surface protein of S. neurona merozoites that is 
abundantly expressed [111]. SnSPR1 has a signal peptide and is present on the outer 
surface of merozoites and is expressed throughout intracellular development of the 
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parasite. Treatment of parasites with α-SnSPR1 resulted into 23% inhibition of invasion, 
suggesting that this protein may play a role in host cell attachment and/or invasion [111].  
The S. neurona genome database may be mined to search for more surface protein that 
may participate in host cell attachment and/or invasion. There is one more superfamily of 
surface antigens unrelated to SRSs called SUSA genes (SAG-Unrelated Surface Antigen 
genes) identified in T. gondii and N. caninum [53, 118]. In T. gondii, there are a total of 
31 SUSA genes identified, these are predicted to encode the proteins which are anchored 
onto the parasite surface by GPI anchor but are unrelated to the SAG/SRS proteins. The 
SUSA proteins are also believed to play role in virulence and interaction with host 
immune system [118]. SUSA1 has been found to be up-regulated in the bradyzoite stage 
of T. gondii [118]. Further, SUSA1 has also been found to be associated with persistence 
of chronic infection and interact with host immune system during infection [118]. 
Currently, we do not know if S. neurona possess any SUSA genes. The parasite’s genome 
data can be mined to identify SUSA genes that can then be explored further for their role 
in parasite survival, virulence, and host-parasite interactions. 
In conclusion, the surface antigens in S. neurona remain appealing. Recombinant 
antigens of SnSAG2 and SnSAG4/3 are being used to run diagnostic assays routinely to 
detect antibodies against S. neurona in sera samples. The surface antigens may also be 
targeted to design novel therapeutics or prophylactic measures. The present study has 
expanded the gene family of surface antigens (SnSAGs) in S. neurona, has investigated 
the functional role of these SnSAGs in host cell attachment/or invasion, and has revealed 
stage-specific expression of the SnSAGs. The information acquired about the stage-
specific expression of the SnSAGs, identification of new SnSAG paralogues, and their 
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functional characterization will help to understand the importance of the SnSAG proteins 
for parasite survival and could lead to improved methods for EPM prevention and/or 
treatment. 
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